ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
10939	AFG3 like matrix AAA peptidase subunit 2(AFG3L2)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006508~proteolysis,GO:0007409~axonogenesis,GO:0007528~neuromuscular junction development,GO:0008053~mitochondrial fusion,GO:0021675~nerve development,GO:0034982~mitochondrial protein processing,GO:0036444~calcium ion transmembrane import into mitochondrion,GO:0040014~regulation of multicellular organism growth,GO:0042407~cristae formation,GO:0042552~myelination,GO:0045041~protein import into mitochondrial intermembrane space,GO:0048747~muscle fiber development,GO:0051560~mitochondrial calcium ion homeostasis,GO:0060013~righting reflex,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005745~m-AAA complex,GO:0016021~integral component of membrane,	GO:0004176~ATP-dependent peptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0051082~unfolded protein binding,	IPR000642:Peptidase M41,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR005936:Peptidase, FtsH,IPR011546:Peptidase M41, FtsH extracellular,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		610246~Spinocerebellar ataxia 28,614487~Ataxia, spastic, 5, autosomal recessive,		SM00382:AAA,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Hydrolase,Membrane,Metal-binding,Metalloprotease,Mitochondrion,Neurodegeneration,Nucleotide-binding,Protease,Proteomics identification,Reference proteome,Spinocerebellar ataxia,Transmembrane,Transmembrane helix,Zinc,	chain:AFG3-like protein 2,metal ion-binding site:Zinc; catalytic,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,transmembrane region,
56172	ANKH inorganic pyrophosphate transport regulator(ANKH)	Homo sapiens				GO:0001501~skeletal system development,GO:0007626~locomotory behavior,GO:0030500~regulation of bone mineralization,GO:0030505~inorganic diphosphate transport,GO:0035435~phosphate ion transmembrane transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0019867~outer membrane,	GO:0005315~inorganic phosphate transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0030504~inorganic diphosphate transmembrane transporter activity,	IPR009887:Progressive ankylosis,		118600~Chondrocalcinosis 2,123000~Craniometaphyseal dysplasia,			Alternative splicing,Complete proteome,Deafness,Disease mutation,Membrane,Phosphate transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Progressive ankylosis protein homolog,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
10297	APC2, WNT signaling pathway regulator(APC2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0001708~cell fate specification,GO:0007026~negative regulation of microtubule depolymerization,GO:0007389~pattern specification process,GO:0008283~cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016477~cell migration,GO:0030178~negative regulation of Wnt signaling pathway,GO:0035414~negative regulation of catenin import into nucleus,GO:0045595~regulation of cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005884~actin filament,GO:0015630~microtubule cytoskeleton,GO:0016342~catenin complex,GO:0030877~beta-catenin destruction complex,GO:0031258~lamellipodium membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0045295~gamma-catenin binding,	IPR000225:Armadillo,IPR009223:Adenomatous polyposis coli protein, cysteine-rich repeat,IPR009224:SAMP,IPR009234:Adenomatous polyposis coli protein basic domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR026818:Adenomatous polyposis coli (APC)  family,IPR026831:Adenomatous polyposis coli domain,IPR026837:Adenomatous polyposis coli 2,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,			SM00185:ARM,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Wnt signaling pathway,	chain:Adenomatous polyposis coli protein 2,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,region of interest:5 X 20 AA approximate repeat of F-X-V-E- X-T-P-X-C-F-S-R-X-S-S-L-S-S-L-S,region of interest:Interaction with CTNNB1,region of interest:Interaction with MAPRE1 and MAPRE3,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,sequence conflict,sequence variant,splice variant,
245973	ATPase H+ transporting V1 subunit C2(ATP6V1C2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0030177~positive regulation of Wnt signaling pathway,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0046983~protein dimerization activity,	IPR004907:ATPase, V1 complex, subunit C,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Alternative splicing,Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit C 2,sequence variant,splice variant,
23080	AVL9 cell migration associated(AVL9)	Homo sapiens				GO:0016477~cell migration,	GO:0016021~integral component of membrane,GO:0055037~recycling endosome,		IPR018307:Late secretory pathway protein AVL9,					Alternative splicing,Complete proteome,Endosome,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Late secretory pathway protein AVL9 homolog,sequence variant,splice variant,transmembrane region,
116986	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2(AGAP2)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0015031~protein transport,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0042177~negative regulation of protein catabolic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0060749~mammary gland alveolus development,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0030295~protein kinase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001806:Small GTPase superfamily,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,GTP-binding,GTPase activation,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,Tumor suppressor,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,domain:Arf-GAP,domain:PH,helix,modified residue,nucleotide phosphate-binding region:GTP,region of interest:G domain,region of interest:Interaction with EPB41L1,region of interest:Interaction with PLCG1,region of interest:Interactions with HOMER1 and NF2,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
8938	BAI1 associated protein 3(BAIAP3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007269~neurotransmitter secretion,	GO:0098793~presynapse,	GO:0008022~protein C-terminus binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR014770:Munc13 homology 1,IPR014772:Mammalian uncoordinated homology 13, domain 2,IPR019558:Mammalian uncoordinated homology 13, subgroup, domain 2,	hsa05202:Transcriptional misregulation in cancer,			SM00239:C2,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:BAI1-associated protein 3,domain:C2 1,domain:C2 2,domain:MHD1,domain:MHD2,sequence variant,splice variant,
10018	BCL2 like 11(BCL2L11)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001822~kidney development,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0002262~myeloid cell homeostasis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007127~meiosis I,GO:0007160~cell-matrix adhesion,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030879~mammary gland development,GO:0032464~positive regulation of protein homooligomerization,GO:0034976~response to endoplasmic reticulum stress,GO:0035148~tube formation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043583~ear development,GO:0045787~positive regulation of cell cycle,GO:0046620~regulation of organ growth,GO:0048066~developmental pigmentation,GO:0048070~regulation of developmental pigmentation,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048563~post-embryonic organ morphogenesis,GO:0060139~positive regulation of apoptotic process by virus,GO:0060154~cellular process regulating host cell cycle in response to virus,GO:0070242~thymocyte apoptotic process,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902263~apoptotic process involved in embryonic digit morphogenesis,GO:1903896~positive regulation of IRE1-mediated unfolded protein response,GO:2000271~positive regulation of fibroblast apoptotic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005868~cytoplasmic dynein complex,GO:0012505~endomembrane system,GO:0019898~extrinsic component of membrane,GO:0097140~BIM-BCL-xl complex,GO:0097141~BIM-BCL-2 complex,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0045502~dynein binding,	IPR014771:Apoptosis, Bim N-terminal,IPR015040:Bcl-x interacting,IPR017288:Bcl-2-like protein 11,	hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05206:MicroRNAs in cancer,		PIRSF037827:Bcl-2-like protein 11,		3D-structure,Alternative splicing,Apoptosis,Complete proteome,Membrane,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Bcl-2-like protein 11,helix,modified residue,sequence conflict,short sequence motif:BH3,splice variant,
91653	BOC cell adhesion associated, oncogene regulated(BOC)	Homo sapiens				GO:0007155~cell adhesion,GO:0007224~smoothened signaling pathway,GO:0007411~axon guidance,GO:0045663~positive regulation of myoblast differentiation,GO:0051149~positive regulation of muscle cell differentiation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0044295~axonal growth cone,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Brother of CDO,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
8896	BUD31 homolog(BUD31)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:2000825~positive regulation of androgen receptor activity,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005681~spliceosomal complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035257~nuclear hormone receptor binding,	IPR001748:G10 protein,IPR018230:BUD31/G10-related, conserved site,	hsa03040:Spliceosome,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Protein BUD31 homolog,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
58191	C-X-C motif chemokine ligand 16(CXCL16)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006935~chemotaxis,GO:0010818~T cell chemotaxis,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0034612~response to tumor necrosis factor,GO:0071222~cellular response to lipopolysaccharide,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005041~low-density lipoprotein receptor activity,GO:0005044~scavenger receptor activity,GO:0008009~chemokine activity,	IPR026296:CXC chemokine 16,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Cell membrane,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:C-X-C motif chemokine 16,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:Chemokine,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
404665	CACTIN antisense RNA 1(CACTIN-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C19orf29OS,compositionally biased region:Val-rich,
57524	CASK interacting protein 1(CASKIN1)	Homo sapiens				GO:0007165~signal transduction,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR001452:Src homology-3 domain,IPR001660:Sterile alpha motif domain,IPR002110:Ankyrin repeat,IPR011511:Variant SH3,IPR013761:Sterile alpha motif/pointed domain,IPR020683:Ankyrin repeat-containing domain,IPR027013:Caskin,				SM00248:ANK,SM00326:SH3,SM00454:SAM,	3D-structure,ANK repeat,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Reference proteome,Repeat,SH3 domain,	chain:Caskin-1,compositionally biased region:Pro-rich,domain:SAM 1,domain:SAM 2,domain:SH3,modified residue,region of interest:CASK-binding,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,
1052	CCAAT/enhancer binding protein delta(CEBPD)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0045444~fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048839~inner ear development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,			PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein delta,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,mutagenesis site,sequence conflict,sequence variant,
971	CD72 molecule(CD72)	Homo sapiens				GO:0007155~cell adhesion,GO:0007165~signal transduction,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04662:B cell receptor signaling pathway,			SM00034:CLECT,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:B-cell differentiation antigen CD72,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
284106	CDGSH iron sulfur domain 3(CISD3)	Homo sapiens					GO:0005739~mitochondrion,	GO:0046872~metal ion binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR018967:Iron sulphur-containing domain, CDGSH-type,				SM00704:ZnF_CDGSH,	2Fe-2S,Acetylation,Complete proteome,Iron,Iron-sulfur,Metal-binding,Mitochondrion,Reference proteome,Transit peptide,	chain:CDGSH iron sulfur domain-containing protein 3, mitochondrial,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 1 (2Fe-2S); via pros nitrogen,metal ion-binding site:Iron-sulfur 2 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (2Fe-2S); via pros nitrogen,modified residue,transit peptide:Mitochondrion,
1353	COX11, cytochrome c oxidase copper chaperone(COX11)	Homo sapiens				GO:0007585~respiratory gaseous exchange,GO:0008535~respiratory chain complex IV assembly,GO:0009060~aerobic respiration,GO:0033132~negative regulation of glucokinase activity,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0004129~cytochrome-c oxidase activity,GO:0005507~copper ion binding,GO:0009055~electron carrier activity,	IPR007533:Cytochrome c oxidase assembly protein CtaG/Cox11,IPR023471:Cytochrome c oxidase assembly protein CtaG/Cox11, domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,		PIRSF005413:cytochrome c oxidase assembly protein, COX11 type,		Alternative splicing,Complete proteome,Copper,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:Cytochrome c oxidase assembly protein COX11, mitochondrial,sequence conflict,sequence variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transit peptide:Mitochondrion,transmembrane region,
1399	CRK like proto-oncogene, adaptor protein(CRKL)	Homo sapiens		h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_integrinPathway:Integrin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pyk2Pathway:Links between Pyk2 and Map Kinases,		GO:0000186~activation of MAPKK activity,GO:0001568~blood vessel development,GO:0007254~JNK cascade,GO:0007265~Ras protein signal transduction,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0009952~anterior/posterior pattern specification,GO:0035556~intracellular signal transduction,GO:0048538~thymus development,GO:0060017~parathyroid gland development,GO:0098609~cell-cell adhesion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005768~endosome,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04666:Fc gamma R-mediated phagocytosis,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05220:Chronic myeloid leukemia,			SM00252:SH2,SM00326:SH3,	3D-structure,Complete proteome,Phosphoprotein,Reference proteome,Repeat,SH2 domain,SH3 domain,	chain:Crk-like protein,domain:SH2,domain:SH3 1,domain:SH3 2,helix,modified residue,strand,
55152	DALR anticodon binding domain containing 3(DALRD3)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006420~arginyl-tRNA aminoacylation,		GO:0004812~aminoacyl-tRNA ligase activity,GO:0004814~arginine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR008909:DALR anticodon binding,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,				SM00836:SM00836,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:DALR anticodon-binding domain-containing protein 3,sequence conflict,sequence variant,splice variant,
64794	DEAD-box helicase 31(DDX31)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,GO:0042254~ribosome biogenesis,	GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM01178:SM01178,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX31,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
55760	DEAH-box helicase 32 (putative)(DHX32)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000398~mRNA splicing, via spliceosome,	GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR007502:Helicase-associated domain,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00847:SM00847,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Mitochondrion,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Putative pre-mRNA-splicing factor ATP- dependent RNA helicase DHX32,domain:Helicase ATP-binding,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,
373863	DND microRNA-mediated repression inhibitor 1(DND1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0060965~negative regulation of gene silencing by miRNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0017091~AU-rich element binding,GO:0035198~miRNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Complete proteome,Cytoplasm,Developmental protein,Nucleus,Reference proteome,Repeat,RNA-binding,	chain:Dead end protein homolog 1,domain:RRM 1,domain:RRM 2,
10311	DSCR3 arrestin fold containing(DSCR3)	Homo sapiens				GO:0006886~intracellular protein transport,	GO:0005634~nucleus,GO:0005768~endosome,	GO:0008565~protein transporter activity,	IPR014756:Immunoglobulin E-set,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Down syndrome critical region protein 3,modified residue,
2067	ERCC excision repair 1, endonuclease non-catalytic subunit(ERCC1)	Homo sapiens				GO:0000710~meiotic mismatch repair,GO:0000720~pyrimidine dimer repair by nucleotide-excision repair,GO:0001302~replicative cell aging,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006312~mitotic recombination,GO:0006949~syncytium formation,GO:0006979~response to oxidative stress,GO:0007283~spermatogenesis,GO:0007584~response to nutrient,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009650~UV protection,GO:0009744~response to sucrose,GO:0010165~response to X-ray,GO:0010259~multicellular organism aging,GO:0032205~negative regulation of telomere maintenance,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035166~post-embryonic hemopoiesis,GO:0035264~multicellular organism growth,GO:0036297~interstrand cross-link repair,GO:0045190~isotype switching,GO:0048477~oogenesis,GO:0048568~embryonic organ development,GO:0070911~global genome nucleotide-excision repair,GO:0070914~UV-damage excision repair,GO:0090656~t-circle formation,GO:1904431~positive regulation of t-circle formation,	GO:0000109~nucleotide-excision repair complex,GO:0000110~nucleotide-excision repair factor 1 complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,GO:0070522~ERCC4-ERCC1 complex,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0001094~TFIID-class transcription factor binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0019904~protein domain specific binding,GO:0043566~structure-specific DNA binding,	IPR004579:DNA repair protein rad10,IPR010994:RuvA domain 2-like,IPR011335:Restriction endonuclease  type II-like,	hsa03420:Nucleotide excision repair,hsa03460:Fanconi anemia pathway,	610758~Cerebrooculofacioskeletal syndrome 4,			3D-structure,Acetylation,Alternative splicing,Cataract,Complete proteome,Cytoplasm,DNA damage,DNA repair,DNA-binding,Endonuclease,Hydrolase,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA excision repair protein ERCC-1,helix,sequence variant,short sequence motif:Nuclear localization signal,strand,
692224	FBXO22 antisense RNA 1(FBXO22-AS1)	Homo sapiens													chain:F-box only protein 22,domain:F-box,modified residue,sequence conflict,splice variant,
2175	Fanconi anemia complementation group A(FANCA)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0006461~protein complex assembly,GO:0007140~male meiosis,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,GO:0045589~regulation of regulatory T cell differentiation,GO:0050727~regulation of inflammatory response,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:2000348~regulation of CD40 signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,	IPR003516:Fanconi anaemia group A protein,	hsa03460:Fanconi anemia pathway,	227650~Fanconi anemia, complementation group A,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Fanconi anemia group A protein,modified residue,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
55215	Fanconi anemia complementation group I(FANCI)	Homo sapiens				GO:0006281~DNA repair,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0031398~positive regulation of protein ubiquitination,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0070182~DNA polymerase binding,	IPR026171:Fanconi anemia group I protein,	hsa03460:Fanconi anemia pathway,	609053~Fanconi anemia, complementation group I,			Alternative splicing,Cell cycle,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA-binding,Fanconi anemia,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Fanconi anemia group I protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,splice variant,
55120	Fanconi anemia complementation group L(FANCL)	Homo sapiens				GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0007276~gamete generation,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,	GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019162:Fanconi anemia complex, subunit FancL, WD-repeat containing domain,IPR026848:E3 ubiquitin-protein ligase FANCL,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,	614083~Fanconi anemia, complementation group L,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,DNA repair,Fanconi anemia,Ligase,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase FANCL,mutagenesis site,sequence conflict,sequence variant,zinc finger region:RING-type,
80233	Fanconi anemia core complex associated protein 100(FAAP100)	Homo sapiens				GO:0006281~DNA repair,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,GO:0045111~intermediate filament cytoskeleton,	GO:0003677~DNA binding,GO:0005515~protein binding,		hsa03460:Fanconi anemia pathway,				Alternative splicing,Complete proteome,DNA damage,DNA repair,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia-associated protein of 100 kDa,sequence conflict,sequence variant,splice variant,
199990	Fanconi anemia core complex associated protein 20(FAAP20)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,GO:0019985~translesion synthesis,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0030054~cell junction,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,GO:0031593~polyubiquitin binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0070530~K63-linked polyubiquitin binding,						3D-structure,Alternative splicing,Chromosome,Complete proteome,DNA damage,DNA repair,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Uncharacterized protein C1orf86,sequence conflict,sequence variant,splice variant,
2774	G protein subunit alpha L(GNAL)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,	GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR000367:G-protein alpha subunit, group S,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04020:Calcium signaling pathway,hsa04728:Dopaminergic synapse,hsa04740:Olfactory transduction,hsa05012:Parkinson's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,	615073~Dystonia 25,		SM00275:SM00275,	ADP-ribosylation,Alternative splicing,Complete proteome,Disease mutation,Dystonia,GTP-binding,Isopeptide bond,Lipoprotein,Magnesium,Metal-binding,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transducer,Ubl conjugation,	chain:Guanine nucleotide-binding protein G(olf) subunit alpha,lipid moiety-binding region:N-palmitoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,
29899	G-protein signaling modulator 2(GPSM2)	Homo sapiens				GO:0000132~establishment of mitotic spindle orientation,GO:0007052~mitotic spindle organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050790~regulation of catalytic activity,GO:0051661~maintenance of centrosome location,GO:0060487~lung epithelial cell differentiation,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0045177~apical part of cell,GO:0097431~mitotic spindle pole,	GO:0000166~nucleotide binding,GO:0001965~G-protein alpha-subunit binding,GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,	IPR003109:GoLoco motif,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		604213~Chudley-McCullough syndrome,		SM00028:TPR,SM00390:GoLoco,	3D-structure,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:G-protein-signaling modulator 2,domain:GoLoco 1,domain:GoLoco 2,domain:GoLoco 3,domain:GoLoco 4,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,
2551	GA binding protein transcription factor alpha subunit(GABPA)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0030154~cell differentiation,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,IPR016312:Transcription factor, GA-binding, alpha subunit,IPR024668:GA-binding protein alpha subunit, N-terminal,			PIRSF001703:GA-binding transcription factor,alpha subunit ,	SM00251:SAM_PNT,SM00413:ETS,	Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:GA-binding protein alpha chain,DNA-binding region:ETS,domain:PNT,sequence conflict,sequence variant,
11010	GLI pathogenesis related 1(GLIPR1)	Homo sapiens					GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR001283:Allergen V5/Tpx-1-related,IPR002413:Ves allergen,IPR014044:CAP domain,IPR018244:Allergen V5/Tpx-1-related, conserved site,				SM00198:SCP,	3D-structure,Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Glioma pathogenesis-related protein 1,sequence conflict,sequence variant,signal peptide,transmembrane region,
404266	HOXB cluster antisense RNA 3(HOXB-AS3)	Homo sapiens													chain:Putative uncharacterized protein LOC404266,
57710	KIAA1614(KIAA1614)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1614,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,
51747	LUC7 like 3 pre-mRNA splicing factor(LUC7L3)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005685~U1 snRNP,GO:0016607~nuclear speck,GO:0071004~U2-type prespliceosome,	GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004882:LUC7-related,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Luc7-like protein 3,compositionally biased region:Arg/Ser-rich,compositionally biased region:Glu-rich,modified residue,sequence conflict,splice variant,
116372	LY6/PLAUR domain containing 1(LYPD1)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001775~cell activation,GO:0007271~synaptic transmission, cholinergic,GO:0035094~response to nicotine,GO:0095500~acetylcholine receptor signaling pathway,GO:1903077~negative regulation of protein localization to plasma membrane,GO:2000272~negative regulation of receptor activity,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,	GO:0030550~acetylcholine receptor inhibitor activity,GO:0033130~acetylcholine receptor binding,						Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Signal,	chain:Ly6/PLAUR domain-containing protein 1,domain:UPAR/Ly6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,signal peptide,splice variant,
23101	MCF.2 cell line derived transforming sequence-like 2(MCF2L2)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,		GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001251:CRAL-TRIO domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018159:Spectrin/alpha-actinin,				SM00150:SPEC,SM00233:PH,SM00325:RhoGEF,SM00516:SEC14,	Alternative splicing,Complete proteome,Diabetes mellitus,Guanine-nucleotide releasing factor,Polymorphism,Reference proteome,	chain:Probable guanine nucleotide exchange factor MCF2L2,domain:CRAL-TRIO,domain:DH,domain:PH,repeat:Spectrin,sequence conflict,sequence variant,splice variant,
57409	MIF4G domain containing(MIF4GD)	Homo sapiens				GO:0006417~regulation of translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,	IPR003890:MIF4G-like, type 3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,				SM00543:MIF4G,	Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Proteomics identification,Reference proteome,Translation regulation,	chain:MIF4G domain-containing protein,domain:MIF4G,splice variant,
150291	MORC2 antisense RNA 1(MORC2-AS1)	Homo sapiens													chain:Uncharacterized protein C22orf27,
84864	MYC induced nuclear antigen(MINA)	Homo sapiens			Function unknown,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0018193~peptidyl-amino acid modification,GO:0042254~ribosome biogenesis,GO:0043687~post-translational protein modification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0005506~iron ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0042802~identical protein binding,	IPR003347:JmjC domain,					3D-structure,Alternative splicing,Complete proteome,Dioxygenase,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,Transcription,Transcription regulation,	chain:MYC-induced nuclear antigen,domain:JmjC,sequence conflict,sequence variant,splice variant,
10004	N-acetylated alpha-linked acidic dipeptidase like 1(NAALADL1)	Homo sapiens				GO:0006508~proteolysis,	GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0004180~carboxypeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016805~dipeptidase activity,GO:0046872~metal ion binding,	IPR003137:Protease-associated domain, PA,IPR007365:Transferrin receptor-like, dimerisation domain,IPR007484:Peptidase M28,					3D-structure,Alternative splicing,Carboxypeptidase,Cell membrane,Complete proteome,Dipeptidase,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Multifunctional enzyme,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Charge relay system,active site:Nucleophile; for NAALADase activity,chain:N-acetylated-alpha-linked acidic dipeptidase-like protein,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,region of interest:NAALADase,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
28989	N-terminal Xaa-Pro-Lys N-methyltransferase 1(NTMT1)	Homo sapiens				GO:0006480~N-terminal protein amino acid methylation,GO:0007051~spindle organization,GO:0007059~chromosome segregation,GO:0016571~histone methylation,GO:0018011~N-terminal peptidyl-alanine methylation,GO:0018012~N-terminal peptidyl-alanine trimethylation,GO:0018013~N-terminal peptidyl-glycine methylation,GO:0018016~N-terminal peptidyl-proline dimethylation,GO:0035572~N-terminal peptidyl-serine dimethylation,GO:0035573~N-terminal peptidyl-serine trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0071885~N-terminal protein N-methyltransferase activity,	IPR008576:Protein of unknown function DUF858, methyltransferase-like,			PIRSF016958:S-adenosyl-L-methionine dependent methyltransferase, AD-003 type,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Methyltransferase,Nucleus,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:Methyltransferase-like protein 11A,helix,modified residue,region of interest:S-adenosyl-L-methionine binding,sequence conflict,strand,turn,
26155	NOC2 like nucleolar associated transcriptional repressor(NOC2L)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002903~negative regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0031497~chromatin assembly,GO:0032066~nucleolus to nucleoplasm transport,GO:0034644~cellular response to UV,GO:0035067~negative regulation of histone acetylation,GO:0042273~ribosomal large subunit biogenesis,GO:1901796~regulation of signal transduction by p53 class mediator,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030690~Noc1p-Noc2p complex,GO:0030691~Noc2p-Noc3p complex,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0031491~nucleosome binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,GO:0070491~repressing transcription factor binding,	IPR005343:Nucleolar complex protein 2,IPR016024:Armadillo-type fold,					Apoptosis,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Nucleolar complex protein 2 homolog,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,
8602	NOP14 nucleolar protein(NOP14)	Homo sapiens				GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000472~endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0030490~maturation of SSU-rRNA,GO:0042274~ribosomal small subunit biogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0030686~90S preribosome,GO:0030692~Noc4p-Nop14p complex,GO:0032040~small-subunit processome,	GO:0019899~enzyme binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR007276:Nucleolar protein 14,					Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,rRNA processing,	chain:Nucleolar protein 14,modified residue,sequence variant,splice variant,
54623	PAF1 homolog, Paf1/RNA polymerase II complex component(PAF1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006378~mRNA polyadenylation,GO:0010390~histone monoubiquitination,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0016584~nucleosome positioning,GO:0019827~stem cell population maintenance,GO:0031062~positive regulation of histone methylation,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033523~histone H2B ubiquitination,GO:0034504~protein localization to nucleus,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071222~cellular response to lipopolysaccharide,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016593~Cdc73/Paf1 complex,GO:0030054~cell junction,	GO:0000993~RNA polymerase II core binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR007133:RNA polymerase II-associated, Paf1,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,Wnt signaling pathway,	chain:RNA polymerase II-associated factor 1 homolog,compositionally biased region:Glu-rich,modified residue,sequence conflict,splice variant,
63935	PDX1 C-terminal inhibiting factor 1(PCIF1)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,	GO:0005654~nucleoplasm,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,		IPR001202:WW domain,IPR022035:Phosphorylated CTD interacting factor 1, WW domain,				SM00456:WW,	3D-structure,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Phosphorylated CTD-interacting factor 1,compositionally biased region:Poly-Ser,domain:WW,helix,modified residue,short sequence motif:Nuclear localization signal,strand,turn,
79955	PDZ domain containing 7(PDZD7)	Homo sapiens				GO:0045184~establishment of protein localization,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0060088~auditory receptor cell stereocilium organization,	GO:0002141~stereocilia ankle link,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005929~cilium,GO:1990696~USH2 complex,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR001478:PDZ domain,		276901~Retinal disease in Usher syndrome type IIA, modifier of,605472~Usher syndrome, type IIC, GPR98/PDZD7 digenic,		SM00228:PDZ,	3D-structure,Alternative splicing,Cell projection,Chromosomal rearrangement,Cilium,Complete proteome,Deafness,Nucleus,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Usher syndrome,	chain:PDZ domain-containing protein 7,compositionally biased region:Ser-rich,domain:PDZ 1,domain:PDZ 2,helix,sequence conflict,splice variant,strand,
65018	PTEN induced putative kinase 1(PINK1)	Homo sapiens				GO:0000422~mitophagy,GO:0001934~positive regulation of protein phosphorylation,GO:0002082~regulation of oxidative phosphorylation,GO:0006468~protein phosphorylation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006950~response to stress,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0010310~regulation of hydrogen peroxide metabolic process,GO:0010629~negative regulation of gene expression,GO:0010821~regulation of mitochondrion organization,GO:0010952~positive regulation of peptidase activity,GO:0016050~vesicle organization,GO:0016236~macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0022904~respiratory electron transport chain,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0032148~activation of protein kinase B activity,GO:0032226~positive regulation of synaptic transmission, dopaminergic,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033603~positive regulation of dopamine secretion,GO:0034599~cellular response to oxidative stress,GO:0035307~positive regulation of protein dephosphorylation,GO:0035556~intracellular signal transduction,GO:0036289~peptidyl-serine autophosphorylation,GO:0038203~TORC2 signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043254~regulation of protein complex assembly,GO:0043524~negative regulation of neuron apoptotic process,GO:0045727~positive regulation of translation,GO:0046329~negative regulation of JNK cascade,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0051881~regulation of mitochondrial membrane potential,GO:0051897~positive regulation of protein kinase B signaling,GO:0061136~regulation of proteasomal protein catabolic process,GO:0071456~cellular response to hypoxia,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:0090141~positive regulation of mitochondrial fission,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090258~negative regulation of mitochondrial fission,GO:0097237~cellular response to toxic substance,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:1900407~regulation of cellular response to oxidative stress,GO:1901727~positive regulation of histone deacetylase activity,GO:1902803~regulation of synaptic vesicle transport,GO:1902902~negative regulation of autophagosome assembly,GO:1902958~positive regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903146~regulation of mitophagy,GO:1903147~negative regulation of mitophagy,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1903214~regulation of protein targeting to mitochondrion,GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,GO:1903384~negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,GO:1903751~negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,GO:1903852~positive regulation of cristae formation,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:1904544~positive regulation of free ubiquitin chain polymerization,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2001171~positive regulation of ATP biosynthetic process,	GO:0000151~ubiquitin ligase complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0030424~axon,GO:0031307~integral component of mitochondrial outer membrane,GO:0031932~TORC2 complex,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,GO:0097413~Lewy body,GO:0097449~astrocyte projection,	GO:0000287~magnesium ion binding,GO:0002020~protease binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0010857~calcium-dependent protein kinase activity,GO:0016301~kinase activity,GO:0016504~peptidase activator activity,GO:0031625~ubiquitin protein ligase binding,GO:0043422~protein kinase B binding,GO:0055131~C3HC4-type RING finger domain binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,	hsa05012:Parkinson's disease,	605909~Parkinson disease 6, early onset,		SM00220:S_TKc,	Alternative splicing,ATP-binding,Autophagy,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Neurodegeneration,Nucleotide-binding,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Transit peptide,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PINK1, mitochondrial,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transit peptide:Mitochondrion,transmembrane region,
221749	PX domain containing 1(PXDC1)	Homo sapiens						GO:0035091~phosphatidylinositol binding,	IPR001683:Phox homologous domain,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:PX domain-containing protein C6orf145,domain:PX,sequence variant,
5870	RAB6A, member RAS oncogene family(RAB6A)	Homo sapiens		h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery,		GO:0000042~protein targeting to Golgi,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007264~small GTPase mediated signal transduction,GO:0016032~viral process,GO:0018125~peptidyl-cysteine methylation,GO:0019882~antigen processing and presentation,GO:0034067~protein localization to Golgi apparatus,GO:0034498~early endosome to Golgi transport,GO:0072385~minus-end-directed organelle transport along microtubule,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0032588~trans-Golgi network membrane,GO:0070062~extracellular exosome,GO:0070381~endosome to plasma membrane transport vesicle,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019904~protein domain specific binding,GO:0031489~myosin V binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR013684:Mitochondrial Rho-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,ER-Golgi transport,Golgi apparatus,GTP-binding,Host-virus interaction,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Prenylation,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Ras-related protein Rab-6A,chain:Ras-related protein Rab-6C,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence variant,short sequence motif:Effector region,splice variant,strand,turn,
5928	RB binding protein 4, chromatin remodeling factor(RBBP4)	Homo sapiens		h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,		GO:0006260~DNA replication,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0016575~histone deacetylation,GO:0031497~chromatin assembly,GO:0034080~CENP-A containing nucleosome assembly,GO:0043044~ATP-dependent chromatin remodeling,GO:0045814~negative regulation of gene expression, epigenetic,GO:0051726~regulation of cell cycle,GO:0060416~response to growth hormone,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0016589~NURF complex,GO:0033186~CAF-1 complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0042826~histone deacetylase binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,				SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Direct protein sequencing,DNA replication,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,WD repeat,	chain:Histone-binding protein RBBP4,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,strand,turn,
58517	RNA binding motif protein 25(RBM25)	Homo sapiens				GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0042981~regulation of apoptotic process,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002483:PWI domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,			SM00311:PWI,SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:RNA-binding protein 25,compositionally biased region:Arg-rich,compositionally biased region:Glu-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PWI,domain:RRM,modified residue,region of interest:Necessary for nuclear speckle localization,sequence conflict,splice variant,
9584	RNA binding motif protein 39(RBM39)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005815~microtubule organizing center,GO:0015630~microtubule cytoskeleton,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR006509:Splicing factor, CC1-like,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,	chain:RNA-binding protein 39,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Poly-Ala,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,region of interest:Activating domain,region of interest:Interaction with ESR1 and ESR2,region of interest:Interaction with JUN,region of interest:Interaction with NCOA6,sequence variant,splice variant,strand,turn,
171568	RNA polymerase III subunit H(POLR3H)	Homo sapiens			Transcription,	GO:0006139~nucleobase-containing compound metabolic process,GO:0006351~transcription, DNA-templated,GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0032481~positive regulation of type I interferon production,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005813~centrosome,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,	GO:0001056~RNA polymerase III activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,	IPR004519:DNA-directed RNA polymerase, subunit E/RPC8,IPR005576:RNA polymerase Rpb7, N-terminal,IPR012340:Nucleic acid-binding, OB-fold,IPR013238:RNA polymerase III, subunit Rpc25,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,hsa04623:Cytosolic DNA-sensing pathway,				Alternative splicing,Antiviral defense,Complete proteome,DNA-directed RNA polymerase,Immunity,Innate immunity,Nucleus,Proteomics identification,Reference proteome,Transcription,	chain:DNA-directed RNA polymerase III subunit RPC8,splice variant,
5894	Raf-1 proto-oncogene, serine/threonine kinase(RAF1)	Homo sapiens	100.MAPK_signaling_cascades,102.Cholesterol_Stress_Response,104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,54.T-cell_anergy,67.Ikaros_and_signaling_inhibitors,68.Mitogen_signaling_in_growth_control,83.Growth_factors_Survival_factors_Mitogens,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArr-mapkPathway:Role of -arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_ceramidePathway:Ceramide Signaling Pathway,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0001666~response to hypoxia,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0007190~activation of adenylate cyclase activity,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0030878~thyroid gland development,GO:0031333~negative regulation of protein complex assembly,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034220~ion transmembrane transport,GO:0035019~somatic stem cell population maintenance,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0035773~insulin secretion involved in cellular response to glucose stimulus,GO:0035994~response to muscle stretch,GO:0042060~wound healing,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045104~intermediate filament cytoskeleton organization,GO:0045595~regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048538~thymus development,GO:0060324~face development,GO:0071550~death-inducing signaling complex assembly,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000145~regulation of cell motility,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031143~pseudopodium,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001427:Ribonuclease A,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR003116:Raf-like Ras-binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020454:Diacylglycerol/phorbol-ester binding,IPR023411:Ribonuclease A, active site,IPR023412:Ribonuclease A-domain,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05034:Alcoholism,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	611553~Noonan syndrome 5,611554~LEOPARD syndrome 2,615916~Cardiomyopathy, dilated, 1NN,		SM00092:RNAse_Pc,SM00109:C1,SM00220:S_TKc,SM00455:RBD,	3D-structure,Alternative splicing,ATP-binding,Cardiomyopathy,Cell membrane,Complete proteome,Cytoplasm,Deafness,Direct protein sequencing,Disease mutation,Disulfide bond,Endonuclease,Hydrolase,Kinase,Membrane,Metal-binding,Methylation,Mitochondrion,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:RAF proto-oncogene serine/threonine- protein kinase,domain:Protein kinase,domain:RBD,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:Phorbol-ester/DAG-type,
23526	Rho GTPase activating protein 45(ARHGAP45)	Homo sapiens				GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000198:Rho GTPase-activating protein domain,IPR001060:FCH domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008936:Rho GTPase activation protein,				SM00055:FCH,SM00109:C1,SM00324:RhoGAP,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,GTPase activation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Minor histocompatibility protein HA-1,domain:Rho-GAP,modified residue,peptide:Minor histocompatibility antigen HA-1,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
84904	Rho guanine nucleotide exchange factor 39(ARHGEF39)	Homo sapiens				GO:0030335~positive regulation of cell migration,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005886~plasma membrane,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000219:Dbl homology (DH) domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Cell membrane,Complete proteome,Guanine-nucleotide releasing factor,Membrane,Polymorphism,Reference proteome,	chain:Vav-like protein C9orf100,domain:DH,domain:PH,sequence conflict,sequence variant,splice variant,
79729	SH3 domain containing 21(SH3D21)	Homo sapiens					GO:0070062~extracellular exosome,		IPR001452:Src homology-3 domain,IPR011511:Variant SH3,IPR013315:Spectrin alpha chain, SH3 domain,				SM00326:SH3,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,
6464	SHC adaptor protein 1(SHC1)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_ghPathway:Growth Hormone Signaling Pathway,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il4Pathway:IL 4 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_mapkPathway:MAPKinase Signaling Pathway,h_ngfPathway:Nerve growth factor pathway (NGF),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001525~angiogenesis,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor-activated receptor activity,GO:0007265~Ras protein signal transduction,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0016032~viral process,GO:0016337~single organismal cell-cell adhesion,GO:0031532~actin cytoskeleton reorganization,GO:0035556~intracellular signal transduction,GO:0036498~IRE1-mediated unfolded protein response,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0040008~regulation of growth,GO:0043547~positive regulation of GTPase activity,GO:0045740~positive regulation of DNA replication,GO:0050900~leukocyte migration,GO:0071363~cellular response to growth factor stimulus,	GO:0005622~intracellular,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070435~Shc-EGFR complex,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0046875~ephrin receptor binding,GO:0048408~epidermal growth factor binding,	IPR000980:SH2 domain,IPR006019:Phosphotyrosine interaction (PID/PI),IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04650:Natural killer cell mediated cytotoxicity,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa05034:Alcoholism,hsa05100:Bacterial invasion of epithelial cells,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05220:Chronic myeloid leukemia,			SM00252:SH2,SM00462:PTB,	3D-structure,Acetylation,Alternative promoter usage,Alternative splicing,Angiogenesis,Complete proteome,Cytoplasm,Growth regulation,Host-virus interaction,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:SHC-transforming protein 1,compositionally biased region:Pro-rich,domain:PID,domain:SH2,helix,modified residue,region of interest:CH1,sequence conflict,sequence variant,splice variant,strand,turn,
283687	ST20 antisense RNA 1(ST20-AS1)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C15orf37,sequence variant,
10273	STIP1 homology and U-box containing protein 1(STUB1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0016567~protein ubiquitination,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030579~ubiquitin-dependent SMAD protein catabolic process,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031398~positive regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0031943~regulation of glucocorticoid metabolic process,GO:0032091~negative regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0036503~ERAD pathway,GO:0038128~ERBB2 signaling pathway,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0051604~protein maturation,GO:0051865~protein autoubiquitination,GO:0070534~protein K63-linked ubiquitination,GO:0071218~cellular response to misfolded protein,GO:0090035~positive regulation of chaperone-mediated protein complex assembly,	GO:0000151~ubiquitin ligase complex,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030018~Z disc,GO:0031371~ubiquitin conjugating enzyme complex,GO:0042405~nuclear inclusion body,GO:0045111~intermediate filament cytoskeleton,GO:0070062~extracellular exosome,	GO:0001664~G-protein coupled receptor binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0030544~Hsp70 protein binding,GO:0030674~protein binding, bridging,GO:0030911~TPR domain binding,GO:0031625~ubiquitin protein ligase binding,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0051787~misfolded protein binding,GO:0051879~Hsp90 protein binding,GO:0061630~ubiquitin protein ligase activity,GO:1904264~ubiquitin protein ligase activity involved in ERAD pathway,	IPR003613:U box domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019734:Tetratricopeptide repeat,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,	615768~Spinocerebellar ataxia, autosomal recessive 16,		SM00028:TPR,SM00504:Ubox,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,Isopeptide bond,Ligase,Neurodegeneration,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,Ubl conjugation,Ubl conjugation pathway,	chain:STIP1 homology and U box-containing protein 1,domain:U-box,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,splice variant,
23517	Ski2 like RNA helicase 2(SKIV2L2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000398~mRNA splicing, via spliceosome,GO:0000460~maturation of 5.8S rRNA,GO:0006364~rRNA processing,GO:0006401~RNA catabolic process,	GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0071013~catalytic step 2 spliceosome,	GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012961:DSH, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016438:RNA helicase, ATP-dependent, SK12/DOB1,IPR025696:rRNA-processing arch domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03018:RNA degradation,		PIRSF005198:antiviral helicase, SKI2 type,	SM00487:DEXDc,SM00490:HELICc,SM01142:SM01142,	Acetylation,ATP-binding,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,Isopeptide bond,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,rRNA processing,Spliceosome,Ubl conjugation,	chain:Superkiller viralicidic activity 2-like 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEIH box,
83860	TATA-box binding protein associated factor 3(TAF3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0051457~maintenance of protein location in nucleus,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,	GO:0002039~p53 binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001965:Zinc finger, PHD-type,IPR006565:Bromodomain transcription factor,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	hsa03022:Basal transcription factors,hsa05168:Herpes simplex infection,			SM00249:PHD,SM00576:BTP,	3D-structure,Acetylation,Complete proteome,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcription initiation factor TFIID subunit 3,compositionally biased region:Lys-rich,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,mutagenesis site,sequence conflict,sequence variant,zinc finger region:PHD-type,
6878	TATA-box binding protein associated factor 6(TAF6)	Homo sapiens			Transcription,	GO:0006352~DNA-templated transcription, initiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0045786~negative regulation of cell cycle,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,GO:0033276~transcription factor TFTC complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR004823:TATA box binding protein associated factor (TAF),IPR009072:Histone-fold,IPR011442:Domain of unknown function DUF1546,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa03022:Basal transcription factors,hsa05168:Herpes simplex infection,			SM00803:TAF,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription initiation factor TFIID subunit 6,modified residue,sequence conflict,sequence variant,splice variant,
26000	TBC1 domain family member 10B(TBC1D10B)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0007165~signal transduction,GO:0031338~regulation of vesicle fusion,GO:0042147~retrograde transport, endosome to Golgi,GO:0043087~regulation of GTPase activity,GO:0090630~activation of GTPase activity,GO:1902017~regulation of cilium assembly,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,	IPR000195:Rab-GTPase-TBC domain,				SM00164:TBC,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,GTPase activation,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:TBC1 domain family member 10B,compositionally biased region:Poly-Pro,domain:Rab-GAP TBC,modified residue,sequence conflict,splice variant,
80185	TELO2 interacting protein 2(TTI2)	Homo sapiens							IPR016024:Armadillo-type fold,IPR018870:Protein of unknown function DUF2454,		615541~Mental retardation, autosomal recessive 39,			Complete proteome,Disease mutation,Mental retardation,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C8orf41,sequence conflict,sequence variant,
90326	THAP domain containing 3(THAP3)	Homo sapiens						GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006612:Zinc finger, C2CH-type,IPR026520:THAP domain-containing protein 3,				SM00692:DM3,SM00980:SM00980,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:THAP domain-containing protein 3,sequence conflict,splice variant,zinc finger region:THAP-type,
25917	THUMP domain containing 3(THUMPD3)	Homo sapiens			DNA replication, recombination, and repair,	GO:0030488~tRNA methylation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0016423~tRNA (guanine) methyltransferase activity,	IPR000241:Putative RNA methylase domain,IPR004114:THUMP,				SM00981:SM00981,	Complete proteome,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transferase,	chain:THUMP domain-containing protein 3,compositionally biased region:Poly-Lys,domain:THUMP,sequence conflict,sequence variant,
10131	TNF receptor associated protein 1(TRAP1)	Homo sapiens				GO:0006457~protein folding,GO:0006950~response to stress,GO:0009386~translational attenuation,GO:0061077~chaperone-mediated protein folding,GO:1901856~negative regulation of cellular respiration,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1903751~negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005811~lipid particle,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR001404:Heat shock protein Hsp90,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020575:Heat shock protein Hsp90, N-terminal,			PIRSF002583:heat shock protein, HSP90/HTPG types,	SM00387:HATPase_c,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chaperone,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Stress response,Transit peptide,	binding site:ATP,binding site:ATP; via amide nitrogen,chain:Heat shock protein 75 kDa, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
26146	TRAF3 interacting protein 1(TRAF3IP1)	Homo sapiens				GO:0001738~morphogenesis of a polarized epithelium,GO:0001822~kidney development,GO:0001933~negative regulation of protein phosphorylation,GO:0021532~neural tube patterning,GO:0031076~embryonic camera-type eye development,GO:0031333~negative regulation of protein complex assembly,GO:0032480~negative regulation of type I interferon production,GO:0032688~negative regulation of interferon-beta production,GO:0035050~embryonic heart tube development,GO:0036342~post-anal tail morphogenesis,GO:0042073~intraciliary transport,GO:0042384~cilium assembly,GO:0042733~embryonic digit morphogenesis,GO:0050687~negative regulation of defense response to virus,GO:0070507~regulation of microtubule cytoskeleton organization,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005930~axoneme,GO:0030992~intraciliary transport particle B,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,GO:0072372~primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0005515~protein binding,GO:0008017~microtubule binding,	IPR018799:TRAF3-interacting protein 1,		616629~Senior-Loken syndrome 9,			3D-structure,Alternative splicing,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Leber congenital amaurosis,Nephronophthisis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Senior-Loken syndrome,	chain:TRAF3-interacting protein 1,compositionally biased region:Arg-rich,helix,modified residue,region of interest:Abolishes microtubules-binding when missing,region of interest:DISC1-interaction domain,sequence variant,splice variant,turn,
284900	TTC28 antisense RNA 1(TTC28-AS1)	Homo sapiens													chain:Uncharacterized protein KIAA1648,
26019	UPF2 regulator of nonsense transcripts homolog (yeast)(UPF2)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0001889~liver development,GO:0006406~mRNA export from nucleus,GO:0031100~organ regeneration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005844~polysome,GO:0035145~exon-exon junction complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042162~telomeric DNA binding,	IPR003890:MIF4G-like, type 3,IPR007193:Up-frameshift suppressor 2,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,			SM00543:MIF4G,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nonsense-mediated mRNA decay,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,	chain:Regulator of nonsense transcripts 2,compositionally biased region:Glu-rich,compositionally biased region:Glu/Lys-rich,domain:MIF4G 1,domain:MIF4G 2,domain:MIF4G 3,helix,modified residue,mutagenesis site,region of interest:Binds to RENT3B,region of interest:Sufficient for interaction with EIF4A1 and SUI1,region of interest:Sufficient for interaction with RENT1,region of interest:Sufficient for interaction with RENT1 C- terminus,region of interest:Sufficient for interaction with RENT3A and RENT3B,sequence conflict,sequence variant,splice variant,strand,
197335	WD repeat domain 90(WDR90)	Homo sapiens			General function prediction only,			GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR007714:Protein of unknown function DUF667,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 90,modified residue,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 14,repeat:WD 15,repeat:WD 16,repeat:WD 17,repeat:WD 18,repeat:WD 19,repeat:WD 2,repeat:WD 20,repeat:WD 21,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,splice variant,
143570	X-ray radiation resistance associated 1(XRRA1)	Homo sapiens				GO:0010165~response to X-ray,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Leucine-rich repeat,Nucleus,Polymorphism,Reference proteome,Repeat,	chain:X-ray radiation resistance-associated protein 1,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,sequence variant,splice variant,
100009676	ZBTB11 antisense RNA 1(ZBTB11-AS1)	Homo sapiens													chain:Putative uncharacterized protein LOC100009676,
100131213	ZNF503 antisense RNA 2(ZNF503-AS2)	Homo sapiens												Complete proteome,Reference proteome,
140701	abhydrolase domain containing 16B(ABHD16B)	Homo sapiens						GO:0016787~hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,					Complete proteome,Hydrolase,Polymorphism,Reference proteome,	chain:Uncharacterized protein C20orf135,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,sequence variant,
50	aconitase 2(ACO2)	Homo sapiens				GO:0006091~generation of precursor metabolites and energy,GO:0006099~tricarboxylic acid cycle,GO:0006101~citrate metabolic process,GO:0006102~isocitrate metabolic process,GO:0008152~metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0043209~myelin sheath,	GO:0003994~aconitate hydratase activity,GO:0005506~iron ion binding,GO:0046872~metal ion binding,GO:0051538~3 iron, 4 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000573:Aconitase A/isopropylmalate dehydratase small subunit, swivel,IPR001030:Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha,IPR006248:Aconitase, mitochondrial-like,IPR015928:Aconitase/3-isopropylmalate dehydratase, swivel,IPR015931:Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3,IPR015932:Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 2,IPR015937:Aconitase/isopropylmalate dehydratase,IPR018136:Aconitase family, 4Fe-4S cluster binding site,	hsa00020:Citrate cycle (TCA cycle),hsa00630:Glyoxylate and dicarboxylate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,	614559~Infantile cerebellar-retinal degeneration,616289~Optic atrophy 9,			4Fe-4S,Acetylation,Complete proteome,Direct protein sequencing,Disease mutation,Iron,Iron-sulfur,Isopeptide bond,Lyase,Metal-binding,Mitochondrion,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Transit peptide,Tricarboxylic acid cycle,	chain:Aconitate hydratase, mitochondrial,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),metal ion-binding site:Iron-sulfur (4Fe-4S),modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
60312	actin filament associated protein 1(AFAP1)	Homo sapiens				GO:0009966~regulation of signal transduction,GO:0051493~regulation of cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,	GO:0003779~actin binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Acetylation,Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Actin filament-associated protein 1,compositionally biased region:Pro-rich,domain:PH 1,domain:PH 2,modified residue,mutagenesis site,region of interest:Interaction with F-actin,sequence conflict,sequence variant,short sequence motif:SH2-binding 1,short sequence motif:SH2-binding 2,short sequence motif:SH3-binding,
109	adenylate cyclase 3(ADCY3)	Homo sapiens				GO:0003091~renal water homeostasis,GO:0006171~cAMP biosynthetic process,GO:0007165~signal transduction,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007338~single fertilization,GO:0007340~acrosome reaction,GO:0007608~sensory perception of smell,GO:0008355~olfactory learning,GO:0009190~cyclic nucleotide biosynthetic process,GO:0019933~cAMP-mediated signaling,GO:0030317~sperm motility,GO:0034199~activation of protein kinase A activity,GO:0035556~intracellular signal transduction,GO:0071377~cellular response to glucagon stimulus,GO:1904322~cellular response to forskolin,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0004016~adenylate cyclase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016849~phosphorus-oxygen lyase activity,GO:0046872~metal ion binding,	IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase,IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site,	hsa00230:Purine metabolism,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04727:GABAergic synapse,hsa04740:Olfactory transduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04925:Aldosterone synthesis and secretion,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05032:Morphine addiction,hsa05110:Vibrio cholerae infection,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05414:Dilated cardiomyopathy,			SM00044:CYCc,	Alternative splicing,ATP-binding,Calmodulin-binding,cAMP biosynthesis,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Glycoprotein,Golgi apparatus,Isopeptide bond,Lyase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Olfaction,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sensory transduction,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Adenylate cyclase type 3,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Magnesium 2; via carbonyl oxygen,sequence variant,topological domain:Cytoplasmic,transmembrane region,
11047	adhesion regulating molecule 1(ADRM1)	Homo sapiens				GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010950~positive regulation of endopeptidase activity,GO:0043248~proteasome assembly,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008541~proteasome regulatory particle, lid subcomplex,GO:0016020~membrane,	GO:0002020~protease binding,GO:0005515~protein binding,GO:0043130~ubiquitin binding,GO:0061133~endopeptidase activator activity,GO:0070628~proteasome binding,	IPR006773:26S proteasome complex ubiquitin receptor, subunit Rpn13,					3D-structure,Acetylation,Complete proteome,Cytoplasm,Isopeptide bond,Nucleus,Phosphoprotein,Proteasome,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Proteasomal ubiquitin receptor ADRM1,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PH,modified residue,region of interest:Interaction with PSMD1,region of interest:Interaction with UCHL5,sequence conflict,
54812	aftiphilin(AFTPH)	Homo sapiens				GO:0015031~protein transport,GO:0046907~intracellular transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030121~AP-1 adaptor complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0030276~clathrin binding,						Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Aftiphilin,modified residue,region of interest:Clathrin-binding,sequence conflict,sequence variant,short sequence motif:WXXF motif 1,short sequence motif:WXXF motif 2,short sequence motif:WXXF motif 3 (partial),short sequence motif:WXXF motif 4,splice variant,
140459	ankyrin repeat and SOCS box containing 6(ASB6)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00253:SOCS,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 6,domain:SOCS box,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,
348094	ankyrin repeat and death domain containing 1A(ANKDD1A)	Homo sapiens				GO:0007165~signal transduction,			IPR000488:Death domain,IPR002110:Ankyrin repeat,IPR011029:Death-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Polymorphism,Reference proteome,Repeat,Signal,	chain:Ankyrin repeat and death domain- containing protein 1A,domain:Death,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence variant,splice variant,
239	arachidonate 12-lipoxygenase, 12S type(ALOX12)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0010656~negative regulation of muscle cell apoptotic process,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0019395~fatty acid oxidation,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0042554~superoxide anion generation,GO:0043066~negative regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043651~linoleic acid metabolic process,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045785~positive regulation of cell adhesion,GO:0045909~positive regulation of vasodilation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051121~hepoxilin metabolic process,GO:0051122~hepoxilin biosynthetic process,GO:0051901~positive regulation of mitochondrial depolarization,GO:0061436~establishment of skin barrier,GO:0071396~cellular response to lipid,GO:0072593~reactive oxygen species metabolic process,GO:0090331~negative regulation of platelet aggregation,GO:1901751~leukotriene A4 metabolic process,GO:2001300~lipoxin metabolic process,GO:2001303~lipoxin A4 biosynthetic process,GO:2001306~lipoxin B4 biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,	GO:0004052~arachidonate 12-lipoxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016165~linoleate 13S-lipoxygenase activity,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0047977~hepoxilin-epoxide hydrolase activity,GO:0051120~hepoxilin A3 synthase activity,	IPR000907:Lipoxygenase,IPR001024:Lipoxygenase, LH2,IPR001885:Lipoxygenase, mammalian,IPR013819:Lipoxygenase, C-terminal,IPR020833:Lipoxygenase, iron binding site,IPR020834:Lipoxygenase, conserved site,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,			SM00308:LH2,	3D-structure,Complete proteome,Cytoplasm,Dioxygenase,Fatty acid metabolism,Hydrolase,Iron,Lipid metabolism,Membrane,Metal-binding,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Arachidonate 12-lipoxygenase, 12S-type,domain:Lipoxygenase,domain:PLAT,helix,metal ion-binding site:Iron; catalytic,metal ion-binding site:Iron; via carboxylate; catalytic,sequence conflict,sequence variant,strand,turn,
384	arginase 2(ARG2)	Homo sapiens				GO:0000050~urea cycle,GO:0001657~ureteric bud development,GO:0006525~arginine metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0006941~striated muscle contraction,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004053~arginase activity,GO:0046872~metal ion binding,	IPR006035:Ureohydrolase,IPR014033:Arginase,IPR020855:Ureohydrolase, manganese-binding site,IPR023696:Ureohydrolase domain,	hsa00220:Arginine biosynthesis,hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,hsa05146:Amoebiasis,		PIRSF036979:ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase,		3D-structure,Arginine metabolism,Complete proteome,Hydrolase,Manganese,Metal-binding,Mitochondrion,Polymorphism,Reference proteome,Transit peptide,Urea cycle,	binding site:Substrate,chain:Arginase-2, mitochondrial,helix,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,region of interest:Substrate binding,sequence variant,strand,transit peptide:Mitochondrion,turn,
79798	armadillo repeat containing 5(ARMC5)	Homo sapiens					GO:0005737~cytoplasm,		IPR000210:BTB/POZ-like,IPR000225:Armadillo,IPR011333:BTB/POZ fold,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,		615954~ACTH-independent macronodular adrenal hyperplasia 2,		SM00185:ARM,	Alternative splicing,Complete proteome,Cushing syndrome,Cytoplasm,Disease mutation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Armadillo repeat-containing protein 5,domain:BTB,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,sequence variant,splice variant,
92714	arrestin domain containing 1(ARRDC1)	Homo sapiens					GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR011021:Arrestin-like, N-terminal,IPR011022:Arrestin C-terminal-like domain,IPR014756:Immunoglobulin E-set,				SM01017:SM01017,	Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Arrestin domain-containing protein 1,compositionally biased region:Pro-rich,sequence variant,
84971	autophagy related 4D cysteine peptidase(ATG4D)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006501~C-terminal protein lipidation,GO:0006612~protein targeting to membrane,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0015031~protein transport,GO:0016485~protein processing,GO:0044804~nucleophagy,GO:0051697~protein delipidation,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0004197~cysteine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,	IPR005078:Peptidase C54,	hsa04140:Regulation of autophagy,				Alternative splicing,Apoptosis,Autophagy,Complete proteome,Cytoplasm,Hydrolase,Mitochondrion,Phosphoprotein,Protease,Protein transport,Proteomics identification,Reference proteome,Thiol protease,Transport,Ubl conjugation pathway,	active site:Nucleophile,chain:Cysteine protease ATG4D,
57448	baculoviral IAP repeat containing 6(BIRC6)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007067~mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0010951~negative regulation of endopeptidase activity,GO:0016567~protein ubiquitination,GO:0032465~regulation of cytokinesis,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0051301~cell division,GO:0060711~labyrinthine layer development,GO:0060712~spongiotrophoblast layer development,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000922~spindle pole,GO:0005768~endosome,GO:0005802~trans-Golgi network,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0030496~midbody,	GO:0004842~ubiquitin-protein transferase activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR001370:Baculoviral inhibition of apoptosis protein repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR022103:Protein of unknown function DUF3643,	hsa04120:Ubiquitin mediated proteolysis,			SM00238:BIR,	3D-structure,Apoptosis,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,Golgi apparatus,Membrane,Mitosis,Phosphoprotein,Protease inhibitor,Proteomics identification,Reference proteome,Thiol protease inhibitor,Transferase,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Baculoviral IAP repeat-containing protein 6,compositionally biased region:Poly-Ala,helix,modified residue,region of interest:Ubiquitin-conjugating,repeat:BIR,sequence conflict,strand,turn,
126792	beta-1,3-galactosyltransferase 6(B3GALT6)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0006486~protein glycosylation,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030203~glycosaminoglycan metabolic process,GO:0030206~chondroitin sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0005797~Golgi medial cisterna,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0035250~UDP-galactosyltransferase activity,GO:0047220~galactosylxylosylprotein 3-beta-galactosyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,	271640~Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures,615349~Ehlers-Danlos syndrome, progeroid type, 2,			Complete proteome,Disease mutation,Dwarfism,Ehlers-Danlos syndrome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-galactosyltransferase 6,compositionally biased region:Poly-Pro,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
10409	brain abundant membrane attached signal protein 1(BASP1)	Homo sapiens				GO:0007356~thorax and anterior abdomen determination,GO:0008406~gonad development,GO:0021762~substantia nigra development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060231~mesenchymal to epithelial transition,GO:0060421~positive regulation of heart growth,GO:0060539~diaphragm development,GO:0072075~metanephric mesenchyme development,GO:0072112~glomerular visceral epithelial cell differentiation,GO:2001076~positive regulation of metanephric ureteric bud development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0016607~nuclear speck,GO:0030054~cell junction,GO:0030426~growth cone,GO:0031982~vesicle,GO:0070062~extracellular exosome,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0044212~transcription regulatory region DNA binding,	IPR008408:Brain acid soluble protein 1,					Alternative splicing,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Isopeptide bond,Lipoprotein,Membrane,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Brain acid soluble protein 1,lipid moiety-binding region:N-myristoyl glycine,modified residue,sequence conflict,sequence variant,splice variant,
25798	brain protein I3(BRI3)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0042802~identical protein binding,	IPR019317:Brain protein I3,					Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Brain protein I3,compositionally biased region:Poly-Pro,sequence conflict,sequence variant,transmembrane region,
55653	breast carcinoma amplified sequence 4(BCAS4)	Homo sapiens				GO:0046907~intracellular transport,	GO:0031083~BLOC-1 complex,		IPR024857:Cappuccino,					Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Breast carcinoma-amplified sequence 4,sequence variant,site:Breakpoint for translocation to form BCAS4-BCAS3,splice variant,
11177	bromodomain adjacent to zinc finger domain 1A(BAZ1A)	Homo sapiens				GO:0006261~DNA-dependent DNA replication,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0008623~CHRAC,GO:0016590~ACF complex,	GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013136:WSTF/Acf1/Cbp146,IPR018359:Bromodomain, conserved site,IPR018501:DDT domain superfamily,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00297:BROMO,SM00571:DDT,	Alternative splicing,Bromodomain,Coiled coil,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Bromodomain adjacent to zinc finger domain protein 1A,domain:Bromo,domain:DDT,domain:WAC,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:PHD-type,
10488	cAMP responsive element binding protein 3(CREB3)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0002230~positive regulation of defense response to virus by host,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006935~chemotaxis,GO:0006990~positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,GO:0016032~viral process,GO:0019043~establishment of viral latency,GO:0019046~release from viral latency,GO:0030335~positive regulation of cell migration,GO:0034976~response to endoplasmic reticulum stress,GO:0042127~regulation of cell proliferation,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0045786~negative regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050930~induction of positive chemotaxis,GO:0051928~positive regulation of calcium ion transport,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090045~positive regulation of deacetylase activity,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:2000326~negative regulation of ligand-dependent nuclear receptor transcription coactivator activity,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016604~nuclear body,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0043025~neuronal cell body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008140~cAMP response element binding protein binding,GO:0031726~CCR1 chemokine receptor binding,GO:0035497~cAMP response element binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,	IPR004827:Basic-leucine zipper domain,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04668:TNF signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04922:Glucagon signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa04931:Insulin resistance,hsa04962:Vasopressin-regulated water reabsorption,hsa05016:Huntington's disease,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05161:Hepatitis B,hsa05203:Viral carcinogenesis,hsa05215:Prostate cancer,			SM00338:BRLZ,	Activator,Alternative splicing,Chemotaxis,Complete proteome,Cytoplasm,DNA-binding,Endoplasmic reticulum,Glycoprotein,Host-virus interaction,Membrane,Nucleus,Reference proteome,Repeat,Repressor,Signal-anchor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Unfolded protein response,	chain:Cyclic AMP-responsive element-binding protein 3,chain:Processed cyclic AMP-responsive element- binding protein 3,compositionally biased region:Pro-rich,DNA-binding region:Basic motif,domain:Leucine-zipper,glycosylation site:N-linked (GlcNAc...),region of interest:Transcription activation (acidic),sequence conflict,short sequence motif:HCFC1-binding-motif (HBM),short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,site:Cleavage; by PS1,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
147968	calpain 12(CAPN12)	Homo sapiens				GO:0006508~proteolysis,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR001300:Peptidase C2, calpain, catalytic domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,				SM00230:CysPc,SM00720:calpain_III,	Calcium,Complete proteome,Hydrolase,Metal-binding,Polymorphism,Protease,Reference proteome,Thiol protease,	chain:Calpain-12,domain:Calpain catalytic,domain:EF-hand,region of interest:Domain III,region of interest:Domain IV,sequence variant,
1376	carnitine palmitoyltransferase 2(CPT2)	Homo sapiens		h_cptPathway:Mitochondrial Carnitine Palmitoyltransferase (CPT) System,		GO:0006635~fatty acid beta-oxidation,GO:0006853~carnitine shuttle,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0004095~carnitine O-palmitoyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR000542:Acyltransferase ChoActase/COT/CPT,	hsa00071:Fatty acid degradation,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,	255110~Myopathy due to CPT II deficiency,600649~CPT deficiency, hepatic, type II,608836~CPT II deficiency, lethal neonatal,614212~Encephalopathy, acute, infection-induced, 4, susceptibility to,			Acetylation,Acyltransferase,Complete proteome,Direct protein sequencing,Disease mutation,Fatty acid metabolism,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,Transport,	active site:Proton acceptor,binding site:Carnitine,chain:Carnitine O-palmitoyltransferase 2, mitochondrial,modified residue,region of interest:Coenzyme A binding,region of interest:Interaction with mitochondrial inner membrane,sequence variant,transit peptide:Mitochondrion,
1453	casein kinase 1 delta(CSNK1D)	Homo sapiens		h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors,h_p35AlzheimersPathway:Deregulation of CDK5 in Alzheimers Disease,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_wntPathway:WNT Signaling Pathway,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0001934~positive regulation of protein phosphorylation,GO:0006281~DNA repair,GO:0006364~rRNA processing,GO:0006468~protein phosphorylation,GO:0006897~endocytosis,GO:0007020~microtubule nucleation,GO:0007030~Golgi organization,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0016055~Wnt signaling pathway,GO:0018105~peptidyl-serine phosphorylation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032922~circadian regulation of gene expression,GO:0034067~protein localization to Golgi apparatus,GO:0035058~nonmotile primary cilium assembly,GO:0042752~regulation of circadian rhythm,GO:0048208~COPII vesicle coating,GO:0051225~spindle assembly,GO:0061512~protein localization to cilium,GO:0071539~protein localization to centrosome,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0098609~cell-cell adhesion,GO:1904340~positive regulation of dopaminergic neuron differentiation,GO:1990090~cellular response to nerve growth factor stimulus,GO:2000052~positive regulation of non-canonical Wnt signaling pathway,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,	GO:0001948~glycoprotein binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042277~peptide binding,GO:0050321~tau-protein kinase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04340:Hedgehog signaling pathway,hsa04390:Hippo signaling pathway,hsa04540:Gap junction,hsa04710:Circadian rhythm,	615224~Advanced sleep-phase syndrome, familial, 2,		SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Biological rhythms,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Golgi apparatus,Kinase,Membrane,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:Casein kinase I isoform delta,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Autoinhibitory,sequence conflict,sequence variant,splice variant,
79172	centromere protein O(CENPO)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR018464:Centromere protein Cenp-O,					Alternative splicing,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Centromere protein O,modified residue,sequence conflict,sequence variant,splice variant,
1133	cholinergic receptor muscarinic 5(CHRM5)	Homo sapiens				GO:0001696~gastric acid secretion,GO:0007197~adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,GO:0007207~phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007271~synaptic transmission, cholinergic,GO:0008283~cell proliferation,GO:0015872~dopamine transport,GO:0019226~transmission of nerve impulse,GO:0060304~regulation of phosphatidylinositol dephosphorylation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030054~cell junction,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0016907~G-protein coupled acetylcholine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000502:Muscarinic acetylcholine receptor M5,IPR000995:Muscarinic acetylcholine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04725:Cholinergic synapse,hsa04810:Regulation of actin cytoskeleton,				Cell junction,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Postsynaptic cell membrane,Receptor,Reference proteome,Synapse,Transducer,Transmembrane,Transmembrane helix,	chain:Muscarinic acetylcholine receptor M5,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
54991	chromosome 1 open reading frame 159(C1orf159)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C1orf159,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,transmembrane region,
414236	chromosome 10 open reading frame 55(C10orf55)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C10orf55,
84167	chromosome 19 open reading frame 44(C19orf44)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C19orf44,splice variant,
755	chromosome 21 open reading frame 2(C21orf2)	Homo sapiens			Function unknown,	GO:0007010~cytoskeleton organization,GO:0007224~smoothened signaling pathway,GO:0008360~regulation of cell shape,GO:0060271~cilium morphogenesis,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0032391~photoreceptor connecting cilium,GO:0036064~ciliary basal body,	GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR003603:U2A'/phosphoprotein 32 family A, C-terminal,				SM00446:LRRcap,	Alternative splicing,Cell projection,Ciliopathy,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Leucine-rich repeat,Mitochondrion,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:Uncharacterized protein C21orf2,modified residue,sequence conflict,sequence variant,splice variant,
63922	chromosome transmission fidelity factor 18(CHTF18)	Homo sapiens				GO:0006260~DNA replication,GO:0007049~cell cycle,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0043142~single-stranded DNA-dependent ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Alternative splicing,ATP-binding,Cell cycle,Complete proteome,DNA replication,DNA-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Chromosome transmission fidelity protein 18 homolog,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
55779	cilia and flagella associated protein 44(CFAP44)	Homo sapiens				GO:0060285~cilium-dependent cell motility,	GO:0042995~cell projection,	GO:0008017~microtubule binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Cell projection,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:WD repeat-containing protein 52,compositionally biased region:Glu-rich,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence variant,
387885	cilia and flagella associated protein 73(CFAP73)	Homo sapiens				GO:0003341~cilium movement,GO:0036159~inner dynein arm assembly,GO:2000574~regulation of microtubule motor activity,	GO:0005737~cytoplasm,GO:0031514~motile cilium,GO:0097545~axonemal outer doublet,	GO:0070840~dynein complex binding,	IPR025252:Domain of unknown function DUF4200,					Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Reference proteome,
54973	cleavage and polyadenylation specific factor 3-like(CPSF3L)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0016180~snRNA processing,GO:0042795~snRNA transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032039~integrator complex,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0016787~hydrolase activity,	IPR001279:Beta-lactamase-like,IPR011108:RNA-metabolising metallo-beta-lactamase,IPR022712:Beta-Casp domain,				SM00849:SM00849,SM01027:SM01027,	Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Proteomics identification,Reference proteome,	chain:Integrator complex subunit 11,mutagenesis site,sequence conflict,short sequence motif:HXHXDH motif,splice variant,
1400	collapsin response mediator protein 1(CRMP1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0006139~nucleobase-containing compound metabolic process,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0010977~negative regulation of neuron projection development,GO:1904530~negative regulation of actin filament binding,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,GO:0031005~filamin binding,	IPR006680:Amidohydrolase 1,IPR011059:Metal-dependent hydrolase, composite domain,IPR011778:Hydantoinase/dihydropyrimidinase,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Methylation,Nitration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Dihydropyrimidinase-related protein 1,modified residue,sequence conflict,sequence variant,
10815	complexin 1(CPLX1)	Homo sapiens				GO:0006836~neurotransmitter transport,GO:0006887~exocytosis,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0014047~glutamate secretion,GO:0016079~synaptic vesicle exocytosis,GO:0017157~regulation of exocytosis,GO:0030073~insulin secretion,	GO:0005829~cytosol,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0070032~synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,GO:0070554~synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,	GO:0005326~neurotransmitter transporter activity,GO:0017075~syntaxin-1 binding,	IPR008849:Synaphin,	hsa04721:Synaptic vesicle cycle,				3D-structure,Coiled coil,Complete proteome,Cytoplasm,Exocytosis,Neurotransmitter transport,Proteomics identification,Reference proteome,Transport,	chain:Complexin-1,region of interest:Interaction with the SNARE complex,
9382	component of oligomeric golgi complex 1(COG1)	Homo sapiens				GO:0000301~retrograde transport, vesicle recycling within Golgi,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0017119~Golgi transport complex,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,			611209~Congenital disorder of glycosylation, type IIg,			Acetylation,Complete proteome,Congenital disorder of glycosylation,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Conserved oligomeric Golgi complex subunit 1,modified residue,sequence variant,
131544	crystallin beta-gamma domain containing 3(CRYBG3)	Homo sapiens						GO:0030246~carbohydrate binding,	IPR000772:Ricin B lectin domain,IPR001064:Beta/gamma crystallin,IPR011024:Gamma-crystallin-related,				SM00247:XTALbg,SM00458:RICIN,	Alternative splicing,Complete proteome,Lectin,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Beta/gamma crystallin domain-containing protein 3,domain:Beta/gamma crystallin 'Greek key' 1,domain:Beta/gamma crystallin 'Greek key' 2,domain:Beta/gamma crystallin 'Greek key' 3,domain:Beta/gamma crystallin 'Greek key' 4,domain:Beta/gamma crystallin 'Greek key' 5,domain:Beta/gamma crystallin 'Greek key' 6,domain:Beta/gamma crystallin 'Greek key' 7,domain:Beta/gamma crystallin 'Greek key' 8,domain:Beta/gamma crystallin 'Greek key' 9,domain:Ricin B-type lectin,sequence conflict,sequence variant,splice variant,
8454	cullin 1(CUL1)	Homo sapiens		h_eradPathway:ERassociated degradation (ERAD) Pathway,h_fbw7Pathway:Cyclin E Destruction Pathway,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_skp2e2fPathway:E2F1 Destruction Pathway,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0016032~viral process,GO:0016055~Wnt signaling pathway,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0050852~T cell receptor signaling pathway,GO:0051403~stress-activated MAPK cascade,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:1990452~Parkin-FBXW7-Cul1 ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,	IPR001373:Cullin, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016157:Cullin, conserved site,IPR016158:Cullin homology,IPR016159:Cullin repeat-like-containing domain,IPR019559:Cullin protein, neddylation domain,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04710:Circadian rhythm,hsa05168:Herpes simplex infection,			SM00182:CULLIN,SM00884:SM00884,	3D-structure,Complete proteome,Host-virus interaction,Isopeptide bond,Methylation,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:Cullin-1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,sequence conflict,strand,turn,
124817	cyclin N-terminal domain containing 1(CNTD1)	Homo sapiens				GO:0007131~reciprocal meiotic recombination,GO:0007283~spermatogenesis,			IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Cyclin N-terminal domain-containing protein 1,domain:Cyclin N-terminal,sequence conflict,sequence variant,splice variant,
1497	cystinosin, lysosomal cystine transporter(CTNS)	Homo sapiens				GO:0002088~lens development in camera-type eye,GO:0006520~cellular amino acid metabolic process,GO:0006749~glutathione metabolic process,GO:0006811~ion transport,GO:0007420~brain development,GO:0007616~long-term memory,GO:0007625~grooming behavior,GO:0007628~adult walking behavior,GO:0008542~visual learning,GO:0015811~L-cystine transport,GO:0042438~melanin biosynthetic process,GO:0046034~ATP metabolic process,GO:0050890~cognition,GO:0055085~transmembrane transport,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,GO:0045111~intermediate filament cytoskeleton,GO:0070062~extracellular exosome,	GO:0015184~L-cystine transmembrane transporter activity,	IPR005282:Lysosomal cystine transporter,IPR006603:Cystinosin/ERS1p repeat,	hsa04142:Lysosome,	219750~Cystinosis, ocular nonnephropathic,219800~Cystinosis, atypical nephropathic,219800~Cystinosis, nephropathic,219900~Cystinosis, late-onset juvenile or adolescent nephropathic,		SM00679:CTNS,	Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Lysosome,Melanin biosynthesis,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Cystinosin,domain:PQ-loop 1,domain:PQ-loop 2,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Lysosomal targeting motif,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
57404	cytochrome P450 family 20 subfamily A member 1(CYP20A1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0055114~oxidation-reduction process,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,					Alternative splicing,Complete proteome,Heme,Iron,Membrane,Metal-binding,Monooxygenase,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 20A1,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,transmembrane region,
11083	death inducer-obliterator 1(DIDO1)	Homo sapiens			Chromatin structure and dynamics,	GO:0006351~transcription, DNA-templated,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,	GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR001965:Zinc finger, PHD-type,IPR003618:Transcription elongation factor S-II, central domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00510:TFS2M,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Death-inducer obliterator 1,compositionally biased region:Arg-rich,compositionally biased region:Pro-rich,domain:TFIIS central,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:PHD-type,
8694	diacylglycerol O-acyltransferase 1(DGAT1)	Homo sapiens				GO:0006641~triglyceride metabolic process,GO:0019432~triglyceride biosynthetic process,GO:0019915~lipid storage,GO:0034379~very-low-density lipoprotein particle assembly,GO:0035336~long-chain fatty-acyl-CoA metabolic process,GO:0036155~acylglycerol acyl-chain remodeling,GO:0042572~retinol metabolic process,GO:0046339~diacylglycerol metabolic process,GO:0055089~fatty acid homeostasis,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003846~2-acylglycerol O-acyltransferase activity,GO:0004144~diacylglycerol O-acyltransferase activity,GO:0005515~protein binding,GO:0008374~O-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0050252~retinol O-fatty-acyltransferase activity,	IPR004299:Membrane bound O-acyl transferase, MBOAT,IPR014371:Sterol O-acyltransferase, ACAT/DAG/ARE types,IPR027251:Diacylglycerol O-acyltransferase 1,	hsa00561:Glycerolipid metabolism,hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,hsa04975:Fat digestion and absorption,	615863~Diarrhea 7,	PIRSF000439:sterol O-acyltransferase, ACAT/DAG/ARE types,PIRSF500231:diacylglycerol O-acyltransferase [Parent=PIRSF000439],		Acyltransferase,Complete proteome,Endoplasmic reticulum,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Diacylglycerol O-acyltransferase 1,modified residue,sequence conflict,transmembrane region,
23033	dopey family member 1(DOPEY1)	Homo sapiens				GO:0006895~Golgi to endosome transport,GO:0007029~endoplasmic reticulum organization,GO:0015031~protein transport,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005802~trans-Golgi network,GO:0005829~cytosol,		IPR007249:Dopey, N-terminal,					Complete proteome,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Protein dopey-1,modified residue,sequence variant,
196385	dynein axonemal heavy chain 10(DNAH10)	Homo sapiens			Cytoskeleton,	GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0030286~dynein complex,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+ ATPase domain,IPR004273:Dynein heavy chain domain,IPR011704:ATPase, dynein-related, AAA domain,IPR013594:Dynein heavy chain, domain-1,IPR013602:Dynein heavy chain, domain-2,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05016:Huntington's disease,			SM00382:AAA,	Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Glycoprotein,Membrane,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transmembrane,Transmembrane helix,	chain:Dynein heavy chain 10, axonemal,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,region of interest:AAA 1,region of interest:AAA 2,region of interest:AAA 3,region of interest:AAA 4,region of interest:AAA 5,region of interest:AAA 6,region of interest:Stalk,region of interest:Stem,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,sequence conflict,sequence variant,short sequence motif:CFDEFNR motif,short sequence motif:GPAGTGKT motif,splice variant,
1760	dystrophia myotonica protein kinase(DMPK)	Homo sapiens				GO:0002028~regulation of sodium ion transport,GO:0006468~protein phosphorylation,GO:0006874~cellular calcium ion homeostasis,GO:0006998~nuclear envelope organization,GO:0008016~regulation of heart contraction,GO:0010657~muscle cell apoptotic process,GO:0010830~regulation of myotube differentiation,GO:0014722~regulation of skeletal muscle contraction by calcium ion signaling,GO:0014853~regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,GO:0018105~peptidyl-serine phosphorylation,GO:0050790~regulation of catalytic activity,GO:0051823~regulation of synapse structural plasticity,GO:1903779~regulation of cardiac conduction,	GO:0005640~nuclear outer membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031307~integral component of mitochondrial outer membrane,GO:0031965~nuclear membrane,GO:0033017~sarcoplasmic reticulum membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017020~myosin phosphatase regulator activity,GO:0031072~heat shock protein binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR014930:Myotonic dystrophy protein kinase, coiled coil,IPR017441:Protein kinase, ATP binding site,		160900~Myotonic dystrophy 1,		SM00133:S_TK_X,SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Cataract,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Endoplasmic reticulum,Kinase,Magnesium,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sarcoplasmic reticulum,Serine/threonine-protein kinase,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Myotonin-protein kinase,domain:AGC-kinase C-terminal,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
953	ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007596~blood coagulation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR000407:Nucleoside phosphatase GDA1/CD39,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa05169:Epstein-Barr virus infection,	615683~Spastic paraplegia 64, autosomal recessive,			Alternative splicing,ATP-binding,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hereditary spastic paraplegia,Hydrolase,Lipoprotein,Magnesium,Membrane,Neurodegeneration,Nucleotide-binding,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Ectonucleoside triphosphate diphosphohydrolase 1,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
27102	eukaryotic translation initiation factor 2 alpha kinase 1(EIF2AK1)	Homo sapiens		h_eif2Pathway:Regulation of eIF2,		GO:0002526~acute inflammatory response,GO:0006909~phagocytosis,GO:0006950~response to stress,GO:0008285~negative regulation of cell proliferation,GO:0009605~response to external stimulus,GO:0010998~regulation of translational initiation by eIF2 alpha phosphorylation,GO:0010999~regulation of eIF2 alpha phosphorylation by heme,GO:0030225~macrophage differentiation,GO:0045993~negative regulation of translational initiation by iron,GO:0046501~protoporphyrinogen IX metabolic process,GO:0046777~protein autophosphorylation,GO:0046986~negative regulation of hemoglobin biosynthetic process,GO:0055072~iron ion homeostasis,	GO:0005737~cytoplasm,	GO:0003743~translation initiation factor activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0005524~ATP binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04141:Protein processing in endoplasmic reticulum,hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Disulfide bond,Initiation factor,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Protein synthesis inhibitor,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Signal,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Eukaryotic translation initiation factor 2-alpha kinase 1,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,repeat:HRM 1,repeat:HRM 2,sequence conflict,sequence variant,splice variant,
138311	family with sequence similarity 69 member B(FAM69B)	Homo sapiens					GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR022049:Uncharacterised protein family FAM69,				SM01299:SM01299,	Alternative splicing,Complete proteome,Disulfide bond,Endoplasmic reticulum,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Protein FAM69B,sequence conflict,sequence variant,splice variant,transmembrane region,
2312	filaggrin(FLG)	Homo sapiens				GO:0007275~multicellular organism development,GO:0030216~keratinocyte differentiation,GO:0061436~establishment of skin barrier,	GO:0005634~nucleus,GO:0005882~intermediate filament,GO:0036457~keratohyalin granule,GO:0043231~intracellular membrane-bounded organelle,	GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR003303:Filaggrin,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,		146700~Ichthyosis vulgaris,605803~Dermatitis, atopic, susceptibility to, 2,		SM01394:SM01394,	3D-structure,Calcium,Citrullination,Coiled coil,Complete proteome,Developmental protein,Direct protein sequencing,Ichthyosis,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:filaggrin,compositionally biased region:Poly-Tyr,compositionally biased region:Ser-rich,domain:EF-hand 1,domain:EF-hand 2,modified residue,repeat:Filaggrin 1,repeat:Filaggrin 10,repeat:Filaggrin 11,repeat:Filaggrin 12,repeat:Filaggrin 13,repeat:Filaggrin 14,repeat:Filaggrin 15,repeat:Filaggrin 16,repeat:Filaggrin 17,repeat:Filaggrin 18,repeat:Filaggrin 19,repeat:Filaggrin 2,repeat:Filaggrin 20,repeat:Filaggrin 21,repeat:Filaggrin 22,repeat:Filaggrin 23,repeat:Filaggrin 3,repeat:Filaggrin 4,repeat:Filaggrin 5,repeat:Filaggrin 6,repeat:Filaggrin 7,repeat:Filaggrin 8,repeat:Filaggrin 9,sequence conflict,sequence variant,
8928	forkhead box H1(FOXH1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001947~heart looping,GO:0003139~secondary heart field specification,GO:0003151~outflow tract morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035054~embryonic heart tube anterior/posterior pattern specification,GO:0035909~aorta morphogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048318~axial mesoderm development,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:1900164~nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,GO:2000824~negative regulation of androgen receptor activity,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0032444~activin responsive factor complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0035326~enhancer binding,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046332~SMAD binding,GO:0050681~androgen receptor binding,GO:0070410~co-SMAD binding,GO:0070412~R-SMAD binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00339:FH,	Activator,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein H1,DNA-binding region:Fork-head,mutagenesis site,region of interest:SMAD-interaction domain (SID),sequence variant,short sequence motif:Fast/FoxH1 motif 1 (FM1),short sequence motif:Fast/FoxH1 motif 2 (FM2),short sequence motif:SMAD interaction motif (SIM),
8322	frizzled class receptor 4(FZD4)	Homo sapiens				GO:0001570~vasculogenesis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007275~multicellular organism development,GO:0007605~sensory perception of sound,GO:0010812~negative regulation of cell-substrate adhesion,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0030947~regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031987~locomotion involved in locomotory behavior,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035426~extracellular matrix-cell signaling,GO:0042701~progesterone secretion,GO:0043507~positive regulation of JUN kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0061299~retina vasculature morphogenesis in camera-type eye,GO:0061301~cerebellum vasculature morphogenesis,GO:0061304~retinal blood vessel morphogenesis,GO:0071300~cellular response to retinoic acid,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0070062~extracellular exosome,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0019955~cytokine binding,GO:0030165~PDZ domain binding,GO:0031625~ubiquitin protein ligase binding,GO:0042803~protein homodimerization activity,GO:0042813~Wnt-activated receptor activity,GO:0046982~protein heterodimerization activity,	IPR000539:Frizzled protein,IPR015526:Frizzled/secreted frizzled-related protein,IPR017981:GPCR, family 2-like,IPR020067:Frizzled domain,IPR026551:Frizzled-4,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	133780~Exudative vitreoretinopathy 1,133780~Retinopathy of prematurity,		SM00063:FRI,SM01330:SM01330,	3D-structure,Cell membrane,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,Wnt signaling pathway,	chain:Frizzled-4,disulfide bond,domain:FZ,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Lys-Thr-X-X-X-Trp motif,short sequence motif:PDZ-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
3964	galectin 8(LGALS8)	Homo sapiens				GO:0098792~xenophagy,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00276:GLECT,SM00908:SM00908,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Lectin,Polymorphism,Proteomics identification,Reference proteome,Repeat,	binding site:Carbohydrate,chain:Galectin-8,domain:Galectin 1,domain:Galectin 2,helix,region of interest:Beta-galactoside binding,sequence conflict,sequence variant,splice variant,strand,turn,
2677	gamma-glutamyl carboxylase(GGCX)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0007596~blood coagulation,GO:0017187~peptidyl-glutamic acid carboxylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008488~gamma-glutamyl carboxylase activity,	IPR007782:Vitamin K-dependent gamma-carboxylase,IPR011020:HTTM,IPR011051:RmlC-like cupin domain,IPR014710:RmlC-like jelly roll fold,	hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis,	277450~Vitamin K-dependent clotting factors, combined deficiency of, 1,610842~Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency,		SM00752:HTTM,	Acetylation,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Lyase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Vitamin K-dependent gamma-carboxylase,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
10020	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase(GNE)	Homo sapiens				GO:0006045~N-acetylglucosamine biosynthetic process,GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006054~N-acetylneuraminate metabolic process,GO:0007155~cell adhesion,GO:0046835~carbohydrate phosphorylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008761~UDP-N-acetylglucosamine 2-epimerase activity,GO:0009384~N-acylmannosamine kinase activity,GO:0016301~kinase activity,GO:0046872~metal ion binding,	IPR000600:ROK,IPR003331:UDP-N-acetylglucosamine 2-epimerase,IPR020004:UDP-N-acetylglucosamine 2-epimerase,UDP-hydrolysing,	hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,	269921~Sialuria,605820~Nonaka myopathy,			3D-structure,Allosteric enzyme,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Kinase,Metal-binding,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Reference proteome,Transferase,Zinc,	chain:Bifunctional UDP-N-acetylglucosamine 2- epimerase/N-acetylmannosamine kinase,helix,nucleotide phosphate-binding region:ATP,region of interest:N-acetylmannosamine kinase,region of interest:UDP-N-acetylglucosamine 2-epimerase,sequence variant,strand,turn,
116444	glutamate ionotropic receptor NMDA type subunit 3B(GRIN3B)	Homo sapiens				GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0051205~protein insertion into membrane,GO:0051924~regulation of calcium ion transport,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0017146~NMDA selective glutamate receptor complex,GO:0030054~cell junction,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0004972~NMDA glutamate receptor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0016594~glycine binding,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,hsa05034:Alcoholism,			SM00079:PBPe,SM00918:SM00918,	Calcium,Cell junction,Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Magnesium,Membrane,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Glutamate [NMDA] receptor subunit 3B,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
26330	glyceraldehyde-3-phosphate dehydrogenase, spermatogenic(GAPDHS)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0030317~sperm motility,GO:0045821~positive regulation of glycolytic process,GO:0061621~canonical glycolysis,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004365~glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0005515~protein binding,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0050661~NADP binding,GO:0051287~NAD binding,	IPR006424:Glyceraldehyde-3-phosphate dehydrogenase, type I,IPR016040:NAD(P)-binding domain,IPR020828:Glyceraldehyde 3-phosphate dehydrogenase, NAD(P) binding domain,IPR020829:Glyceraldehyde 3-phosphate dehydrogenase, catalytic domain,IPR020830:Glyceraldehyde 3-phosphate dehydrogenase, active site,IPR020831:Glyceraldehyde/Erythrose phosphate dehydrogenase family,	hsa00010:Glycolysis / Gluconeogenesis,hsa01100:Metabolic pathways,			SM00846:SM00846,	3D-structure,Complete proteome,Cytoplasm,Glycolysis,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,binding site:Glyceraldehyde 3-phosphate,binding site:NAD,binding site:NAD; via carbonyl oxygen,chain:Glyceraldehyde-3-phosphate dehydrogenase, testis-specific,helix,modified residue,nucleotide phosphate-binding region:NAD,region of interest:Glyceraldehyde 3-phosphate binding,sequence conflict,sequence variant,site:Activates thiol group during catalysis,strand,turn,
10082	glypican 6(GPC6)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0016477~cell migration,GO:0030203~glycosaminoglycan metabolic process,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0043202~lysosomal lumen,	GO:0043395~heparan sulfate proteoglycan binding,GO:1904929~coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,	IPR001863:Glypican,IPR019803:Glypican, conserved site,		258315~Omodysplasia 1,			Cell membrane,Complete proteome,Dwarfism,Glycoprotein,GPI-anchor,Heparan sulfate,Lipoprotein,Membrane,Polymorphism,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Glypican-6,chain:Secreted glypican-6,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,
2803	golgin A4(GOLGA4)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0016192~vesicle-mediated transport,GO:0043001~Golgi to plasma membrane protein transport,GO:0045773~positive regulation of axon extension,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0051020~GTPase binding,	IPR000237:GRIP,				SM00755:Grip,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Golgin subfamily A member 4,compositionally biased region:Glu-rich,domain:GRIP,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
9146	hepatocyte growth factor-regulated tyrosine kinase substrate(HGS)	Homo sapiens		h_eea1Pathway:The role of FYVE-finger proteins in vesicle transport,		GO:0006622~protein targeting to lysosome,GO:0006886~intracellular protein transport,GO:0006914~autophagy,GO:0007165~signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0010324~membrane invagination,GO:0010628~positive regulation of gene expression,GO:0016197~endosomal transport,GO:0036258~multivesicular body assembly,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042176~regulation of protein catabolic process,GO:0043405~regulation of MAP kinase activity,GO:0046426~negative regulation of JAK-STAT cascade,GO:0072657~protein localization to membrane,GO:1903543~positive regulation of exosomal secretion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0031901~early endosome membrane,GO:0032585~multivesicular body membrane,GO:0033565~ESCRT-0 complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019904~protein domain specific binding,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR002014:VHS,IPR003903:Ubiquitin interacting motif,IPR008942:ENTH/VHS,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017073:Ubiquitin binding protein, Hrs/VPS27,IPR017455:Zinc finger, FYVE-related,IPR024641:Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain,	hsa04144:Endocytosis,hsa04145:Phagosome,		PIRSF036956:ubiquitin binding protein, Hrs/Vps27 type,	SM00064:FYVE,SM00288:VHS,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Endosome,Kinase,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transferase,Transport,Ubl conjugation,Zinc,Zinc-finger,	chain:Hepatocyte growth factor-regulated tyrosine kinase substrate,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:VHS,helix,modified residue,mutagenesis site,region of interest:Interaction with NF2,region of interest:Interaction with SNAP25 and TRAK2,region of interest:Interaction with SNX1,region of interest:Interaction with STAM1,repeat:UIM,sequence conflict,sequence variant,splice variant,zinc finger region:FYVE-type,
4670	heterogeneous nuclear ribonucleoprotein M(HNRNPM)	Homo sapiens				GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010467~gene expression,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0042382~paraspeckles,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024666:Heterogeneous nuclear ribonucleoprotein M, PY nuclear localisation signal,IPR024667:Heterogeneous nuclear ribonucleoprotein M,	hsa03040:Spliceosome,			SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Heterogeneous nuclear ribonucleoprotein M,compositionally biased region:Poly-Gly,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,region of interest:27 X 6 AA repeats of [GEVSTPAN]-[ILMV]- [DE]-[RH]-[MLVI]-[GAV],repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,splice variant,strand,turn,
3099	hexokinase 2(HK2)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0001678~cellular glucose homeostasis,GO:0002931~response to ischemia,GO:0006096~glycolytic process,GO:0007595~lactation,GO:0008637~apoptotic mitochondrial changes,GO:0015758~glucose transport,GO:0035795~negative regulation of mitochondrial membrane permeability,GO:0046324~regulation of glucose import,GO:0046835~carbohydrate phosphorylation,GO:0051156~glucose 6-phosphate metabolic process,GO:0061621~canonical glycolysis,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:1904925~positive regulation of mitophagy in response to mitochondrial depolarization,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0005623~cell,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008865~fructokinase activity,GO:0019158~mannokinase activity,	IPR001312:Hexokinase,IPR019807:Hexokinase, conserved site,IPR022672:Hexokinase, N-terminal,IPR022673:Hexokinase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa00524:Butirosin and neomycin biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05230:Central carbon metabolism in cancer,				3D-structure,Acetylation,Allosteric enzyme,ATP-binding,Complete proteome,Glycolysis,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,	binding site:ATP,binding site:ATP 1,binding site:ATP 2,binding site:Glucose-6-phosphate 1,binding site:Glucose-6-phosphate 2,binding site:Substrate 1,binding site:Substrate 2,chain:Hexokinase-2,helix,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Catalytic,region of interest:Glucose-6-phosphate 1 binding,region of interest:Glucose-6-phosphate 2 binding,region of interest:Hydrophobic,region of interest:Regulatory,region of interest:Substrate 1 binding,region of interest:Substrate 2 binding,sequence conflict,sequence variant,strand,turn,
79366	high mobility group nucleosome binding domain 5(HMGN5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006749~glutathione metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0043066~negative regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071157~negative regulation of cell cycle arrest,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0031492~nucleosomal DNA binding,GO:0044822~poly(A) RNA binding,	IPR000079:High mobility group nucleosome-binding domain-containing family,				SM00527:HMG17,	Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:High-mobility group nucleosome-binding domain-containing protein 5,modified residue,
3035	histidyl-tRNA synthetase(HARS)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006427~histidyl-tRNA aminoacylation,GO:0032543~mitochondrial translation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004812~aminoacyl-tRNA ligase activity,GO:0004821~histidine-tRNA ligase activity,GO:0005524~ATP binding,	IPR000738:WHEP-TRS,IPR004154:Anticodon-binding,IPR004516:Histidine-tRNA ligase/ATP phosphoribosyltransferase regulatory subunit,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR009068:S15/NS1, RNA-binding,IPR015807:Histidine-tRNA ligase,	hsa00970:Aminoacyl-tRNA biosynthesis,	614504~Usher syndrome type 3B,616625~Charcot-Marie-Tooth disease, axonal, type 2W,	PIRSF001549:histidyl-tRNA synthetase,	SM00991:SM00991,	3D-structure,Acetylation,Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Cytoplasm,Deafness,Disease mutation,Ligase,Neurodegeneration,Neuropathy,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Retinitis pigmentosa,Usher syndrome,	chain:Histidyl-tRNA synthetase, cytoplasmic,domain:WHEP-TRS,helix,modified residue,sequence conflict,sequence variant,
388697	hornerin(HRNR)	Homo sapiens				GO:0031424~keratinization,GO:0043163~cell envelope organization,GO:0061436~establishment of skin barrier,	GO:0001533~cornified envelope,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030313~cell envelope,GO:0036457~keratohyalin granule,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM01394:SM01394,	Calcium,Complete proteome,Developmental protein,Keratinization,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:antimicrobial peptide E608,chain:Hornerin,domain:EF-hand 1,domain:EF-hand 2,modified residue,region of interest:S-100-like,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,
3038	hyaluronan synthase 3(HAS3)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0007155~cell adhesion,GO:0030213~hyaluronan biosynthetic process,GO:0045226~extracellular polysaccharide biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0085029~extracellular matrix assembly,GO:1900106~positive regulation of hyaluranon cable assembly,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0036117~hyaluranon cable,	GO:0050501~hyaluronan synthase activity,	IPR026107:Hyaluronan synthase/nodulation protein C,IPR026108:Hyaluronan synthase 3,					Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Hyaluronan synthase 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
81888	hydroxypyruvate isomerase (putative)(HYI)	Homo sapiens						GO:0005515~protein binding,GO:0008903~hydroxypyruvate isomerase activity,	IPR013022:Xylose isomerase-like, TIM barrel domain,IPR026040:Hydroxypyruvate isomerase-like,	hsa00630:Glyoxylate and dicarboxylate metabolism,hsa01100:Metabolic pathways,		PIRSF006241:hydroxypyruvate isomerase,		Alternative splicing,Complete proteome,Isomerase,Polymorphism,Proteomics identification,Reference proteome,	chain:Putative hydroxypyruvate isomerase,sequence conflict,sequence variant,splice variant,
3292	hydroxysteroid 17-beta dehydrogenase 1(HSD17B1)	Homo sapiens				GO:0006694~steroid biosynthetic process,GO:0006703~estrogen biosynthetic process,GO:0008210~estrogen metabolic process,GO:0055114~oxidation-reduction process,GO:0060348~bone development,GO:0061370~testosterone biosynthetic process,GO:0071248~cellular response to metal ion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003824~catalytic activity,GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0047035~testosterone dehydrogenase (NAD+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR011348:17beta-dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00140:Steroid hormone biosynthesis,hsa01100:Metabolic pathways,hsa04913:Ovarian steroidogenesis,		PIRSF000095:estradiol 17beta-dehydrogenase,		3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Lipid biosynthesis,Lipid metabolism,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Steroid biosynthesis,	active site:Proton acceptor,binding site:NADP,binding site:Substrate,chain:Estradiol 17-beta-dehydrogenase 1,helix,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,strand,turn,
3425	iduronidase, alpha-L-(IDUA)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0005984~disaccharide metabolic process,GO:0006027~glycosaminoglycan catabolic process,GO:0030207~chondroitin sulfate catabolic process,GO:0030209~dermatan sulfate catabolic process,	GO:0030135~coated vesicle,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0003940~L-iduronidase activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0005102~receptor binding,	IPR000514:Glycoside hydrolase, family 39,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,	hsa00531:Glycosaminoglycan degradation,hsa01100:Metabolic pathways,hsa04142:Lysosome,	607014~Mucopolysaccharidosis Ih,607015~Mucopolysaccharidosis Ih/s,607016~Mucopolysaccharidosis Is,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Mucopolysaccharidosis,Polymorphism,Proteomics identification,Reference proteome,Signal,	active site:Nucleophile,active site:Proton donor,chain:Alpha-L-iduronidase,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
51477	inositol-3-phosphate synthase 1(ISYNA1)	Homo sapiens				GO:0006021~inositol biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0043647~inositol phosphate metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004512~inositol-3-phosphate synthase activity,GO:0005515~protein binding,	IPR002587:Myo-inositol-1-phosphate synthase,IPR013021:Myo-inositol-1-phosphate synthase, GAPDH-like,IPR016040:NAD(P)-binding domain,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF015578:myo-inositol-1-phosphate synthase,		Alternative splicing,Complete proteome,Cytoplasm,Inositol biosynthesis,Isomerase,Lipid biosynthesis,Lipid metabolism,NAD,Phospholipid biosynthesis,Phospholipid metabolism,Proteomics identification,Reference proteome,	chain:Inositol-3-phosphate synthase 1,sequence conflict,splice variant,
10643	insulin like growth factor 2 mRNA binding protein 3(IGF2BP3)	Homo sapiens				GO:0006412~translation,GO:0009653~anatomical structure morphogenesis,GO:0010467~gene expression,GO:0017148~negative regulation of translation,GO:0042035~regulation of cytokine biosynthetic process,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00322:KH,SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Translation regulation,Transport,Ubl conjugation,	chain:Insulin-like growth factor 2 mRNA-binding protein 3,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,domain:RRM 1,domain:RRM 2,helix,modified residue,sequence conflict,splice variant,strand,
3675	integrin subunit alpha 3(ITGA3)	Homo sapiens				GO:0001764~neuron migration,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007507~heart development,GO:0007613~memory,GO:0010628~positive regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010811~positive regulation of cell-substrate adhesion,GO:0010976~positive regulation of neuron projection development,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030111~regulation of Wnt signaling pathway,GO:0030198~extracellular matrix organization,GO:0030324~lung development,GO:0030510~regulation of BMP signaling pathway,GO:0031345~negative regulation of cell projection organization,GO:0034698~response to gonadotropin,GO:0035024~negative regulation of Rho protein signal transduction,GO:0035640~exploration behavior,GO:0042493~response to drug,GO:0043588~skin development,GO:0048333~mesodermal cell differentiation,GO:0050900~leukocyte migration,GO:0060135~maternal process involved in female pregnancy,GO:0072006~nephron development,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0097062~dendritic spine maintenance,GO:0097205~renal filtration,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016323~basolateral plasma membrane,GO:0030426~growth cone,GO:0031527~filopodium membrane,GO:0034667~integrin alpha3-beta1 complex,GO:0043235~receptor complex,GO:0048471~perinuclear region of cytoplasm,GO:0060076~excitatory synapse,GO:0070062~extracellular exosome,GO:0071438~invadopodium membrane,GO:0071944~cell periphery,GO:0097060~synaptic membrane,	GO:0001948~glycoprotein binding,GO:0001968~fibronectin binding,GO:0002020~protease binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0019904~protein domain specific binding,GO:0043236~laminin binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	614748~Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital,		SM00191:Int_alpha,	Alternative splicing,Calcium,Cell adhesion,Cell junction,Cell membrane,Cell projection,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Epidermolysis bullosa,Glycoprotein,Integrin,Lipoprotein,Membrane,Metal-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-3,chain:Integrin alpha-3 heavy chain,chain:Integrin alpha-3 light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:Interaction with HPS5,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence variant,short sequence motif:GFFKR motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221037	jumonji domain containing 1C(JMJD1C)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007596~blood coagulation,GO:0033169~histone H3-K9 demethylation,GO:0055114~oxidation-reduction process,	GO:0000785~chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0046872~metal ion binding,GO:0046966~thyroid hormone receptor binding,GO:0051213~dioxygenase activity,	IPR003347:JmjC domain,	hsa05202:Transcriptional misregulation in cancer,			SM00558:JmjC,	3D-structure,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Dioxygenase,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Probable JmjC domain-containing histone demethylation protein 2C,domain:JmjC,metal ion-binding site:Iron; catalytic,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL motif,splice variant,zinc finger region:C6-type,
57338	junctophilin 3(JPH3)	Homo sapiens			Function unknown,	GO:0007612~learning,GO:0007613~memory,GO:0035640~exploration behavior,GO:0040011~locomotion,GO:0048168~regulation of neuronal synaptic plasticity,GO:0050885~neuromuscular process controlling balance,GO:0051209~release of sequestered calcium ion into cytosol,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0060402~calcium ion transport into cytosol,	GO:0005886~plasma membrane,GO:0014701~junctional sarcoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030314~junctional membrane complex,	GO:0015278~calcium-release channel activity,	IPR003409:MORN motif,IPR017191:Junctophilin,		606438~Huntington disease-like 2,	PIRSF037387:junctophilin,	SM00698:MORN,	Alternative splicing,Cell membrane,Complete proteome,Endoplasmic reticulum,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Triplet repeat expansion,	chain:Junctophilin-3,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,modified residue,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,repeat:MORN 4,repeat:MORN 5,repeat:MORN 6,repeat:MORN 7,repeat:MORN 8,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
79412	kringle containing transmembrane protein 2(KREMEN2)	Homo sapiens		h_wnt-Lrp6Pathway:Wnt/LRP6 Signalling,		GO:0007154~cell communication,GO:0016055~Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,		IPR000001:Kringle,IPR000859:CUB domain,IPR002889:Carbohydrate-binding WSC,IPR013806:Kringle-like fold,IPR017076:Kremen,IPR018056:Kringle, conserved site,			PIRSF036961:kremen protein,	SM00042:CUB,SM00130:KR,SM00321:WSC,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Kringle,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Kremen protein 2,disulfide bond,domain:CUB,domain:Kringle,domain:WSC,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
8564	kynurenine 3-monooxygenase(KMO)	Homo sapiens				GO:0006569~tryptophan catabolic process,GO:0009651~response to salt stress,GO:0019441~tryptophan catabolic process to kynurenine,GO:0019674~NAD metabolic process,GO:0019805~quinolinate biosynthetic process,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0043420~anthranilate metabolic process,GO:0044550~secondary metabolite biosynthetic process,GO:0055114~oxidation-reduction process,GO:0070189~kynurenine metabolic process,	GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004502~kynurenine 3-monooxygenase activity,GO:0016174~NAD(P)H oxidase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0071949~FAD binding,	IPR002938:Monooxygenase, FAD-binding,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027545:Kynurenine 3-monooxygenase,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,FAD,Flavoprotein,Membrane,Mitochondrion,Mitochondrion outer membrane,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Reference proteome,Transmembrane,Transmembrane helix,	chain:Kynurenine 3-monooxygenase,modified residue,sequence variant,splice variant,transmembrane region,
4000	lamin A/C(LMNA)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0007077~mitotic nuclear envelope disassembly,GO:0007084~mitotic nuclear envelope reassembly,GO:0007517~muscle organ development,GO:0030334~regulation of cell migration,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0034504~protein localization to nucleus,GO:0035105~sterol regulatory element binding protein import into nucleus,GO:0036498~IRE1-mediated unfolded protein response,GO:0055015~ventricular cardiac muscle cell development,GO:0071456~cellular response to hypoxia,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0090343~positive regulation of cell aging,GO:1900180~regulation of protein localization to nucleus,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005638~lamin filament,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0016607~nuclear speck,GO:0031012~extracellular matrix,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001322:Lamin Tail Domain,IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	115200~Cardiomyopathy, dilated, 1A,151660~Lipodystrophy, familial partial, 2,159001~Muscular dystrophy, limb-girdle, type 1B,176670~Hutchinson-Gilford progeria,181350~Emery-Dreifuss muscular dystrophy 2, AD,212112~Malouf syndrome,248370~Mandibuloacral dysplasia,275210~Restrictive dermopathy, lethal,605588~Charcot-Marie-Tooth disease, type 2B1,610140~Heart-hand syndrome, Slovenian type,613205~Muscular dystrophy, congenital,616516~Emery-Dreifuss muscular dystrophy 3, AR,		SM01391:SM01391,	3D-structure,Acetylation,Alternative splicing,Cardiomyopathy,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Congenital muscular dystrophy,Direct protein sequencing,Disease mutation,Emery-Dreifuss muscular dystrophy,Intermediate filament,Isopeptide bond,Limb-girdle muscular dystrophy,Lipoprotein,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Lamin-A/C,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence variant,short sequence motif:Nuclear localization signal,site:Heptad change of phase,site:Stutter,splice variant,strand,turn,
4054	latent transforming growth factor beta binding protein 3(LTBP3)	Homo sapiens				GO:0036363~transforming growth factor beta activation,GO:1902462~positive regulation of mesenchymal stem cell proliferation,GO:2000741~positive regulation of mesenchymal stem cell differentiation,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0050431~transforming growth factor beta binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR017878:TB domain,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,IPR026823:Complement Clr-like EGF domain,		601216~Dental anomalies and short stature,		SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Amelogenesis imperfecta,Complete proteome,Disulfide bond,Dwarfism,EGF-like domain,Glycoprotein,Growth factor binding,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Latent-transforming growth factor beta- binding protein 3,compositionally biased region:Cys-rich,compositionally biased region:Gly-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 10; calcium-binding,domain:EGF-like 11; calcium-binding,domain:EGF-like 12; calcium-binding,domain:EGF-like 13; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,domain:TB 1,domain:TB 2,domain:TB 3,domain:TB 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
55379	leucine rich repeat containing 59(LRRC59)	Homo sapiens			Function unknown,	GO:0098609~cell-cell adhesion,	GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0042645~mitochondrial nucleoid,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Leucine-rich repeat,Membrane,Microsome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat-containing protein 59,compositionally biased region:Poly-Leu,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
94059	leukocyte receptor cluster member 9(LENG9)	Homo sapiens						GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR007547:Uncharacterised protein family UPF0248,IPR009097:RNA ligase/cyclic nucleotide phosphodiesterase,IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain,				SM00356:ZnF_C3H1,	Complete proteome,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Leukocyte receptor cluster member 9,sequence variant,zinc finger region:C3H1-type,
254251	ligand dependent nuclear receptor corepressor like(LCORL)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR007889:DNA binding HTH domain, Psq-type,IPR009057:Homeodomain-like,					Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Ligand-dependent nuclear receptor corepressor-like protein,compositionally biased region:Ala-rich,DNA-binding region:H-T-H motif,domain:HTH psq-type,sequence conflict,splice variant,
100128782	long intergenic non-protein coding RNA 476(LINC00476)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C9orf130,
100130581	long intergenic non-protein coding RNA 910(LINC00910)	Homo sapiens													chain:Putative uncharacterized protein FLJ41591,splice variant,
23081	lysine demethylase 4C(KDM4C)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0033169~histone H3-K9 demethylation,GO:0055114~oxidation-reduction process,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0032452~histone demethylase activity,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0050681~androgen receptor binding,GO:0051213~dioxygenase activity,	IPR001965:Zinc finger, PHD-type,IPR002999:Tudor domain,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00249:PHD,SM00333:TUDOR,SM00545:JmjN,SM00558:JmjC,	3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Dioxygenase,Iron,Metal-binding,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	binding site:Alpha-ketoglutarate,chain:Lysine-specific demethylase 4C,domain:JmjC,domain:JmjN,domain:Tudor 1,domain:Tudor 2,metal ion-binding site:Iron; catalytic,metal ion-binding site:Zinc,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
1130	lysosomal trafficking regulator(LYST)	Homo sapiens				GO:0007040~lysosome organization,GO:0015031~protein transport,GO:0030595~leukocyte chemotaxis,GO:0032438~melanosome organization,GO:0032510~endosome to lysosome transport via multivesicular body sorting pathway,GO:0033364~mast cell secretory granule organization,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042742~defense response to bacterium,GO:0042832~defense response to protozoan,GO:0043473~pigmentation,GO:0051607~defense response to virus,	GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,	GO:0005515~protein binding,	IPR000409:BEACH domain,IPR001680:WD40 repeat,IPR011993:Pleckstrin homology-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR023362:PH-BEACH domain,		214500~Chediak-Higashi syndrome,		SM00320:WD40,SM01026:SM01026,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,WD repeat,	chain:Lysosomal-trafficking regulator,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,domain:BEACH,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
23609	makorin ring finger protein 2(MKRN2)	Homo sapiens			General function prediction only,	GO:0016567~protein ubiquitination,	GO:0005622~intracellular,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000571:Zinc finger, CCCH-type,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR026293:Makorin 2,				SM00184:RING,SM00356:ZnF_C3H1,	Alternative splicing,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Probable E3 ubiquitin-protein ligase makorin-2,modified residue,region of interest:Makorin-type Cys-His,sequence conflict,sequence variant,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,zinc finger region:C3H1-type 4,zinc finger region:RING-type,
56246	melanocortin 2 receptor accessory protein(MRAP)	Homo sapiens				GO:0030819~positive regulation of cAMP biosynthetic process,GO:0034394~protein localization to cell surface,GO:0050873~brown fat cell differentiation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0031780~corticotropin hormone receptor binding,GO:0031781~type 3 melanocortin receptor binding,GO:0031782~type 4 melanocortin receptor binding,GO:0031783~type 5 melanocortin receptor binding,GO:0070996~type 1 melanocortin receptor binding,			607398~Glucocorticoid deficiency 2,			Alternative splicing,Cell membrane,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Melanocortin-2 receptor accessory protein,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
4141	methionyl-tRNA synthetase(MARS)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006431~methionyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004825~methionine-tRNA ligase activity,GO:0005524~ATP binding,	IPR000738:WHEP-TRS,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR004046:Glutathione S-transferase, C-terminal,IPR009068:S15/NS1, RNA-binding,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR014758:Methionyl-tRNA synthetase,IPR015413:Methionyl/Leucyl tRNA synthetase,IPR023458:Methionine-tRNA ligase, type 1,	hsa00450:Selenocompound metabolism,hsa00970:Aminoacyl-tRNA biosynthesis,	615486~Interstitial lung and liver disease,616280~Charcot-Marie-Tooth disease, axonal, type 2U,		SM00991:SM00991,	3D-structure,Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Charcot-Marie-Tooth disease,Complete proteome,Cytoplasm,Disease mutation,Ligase,Neurodegeneration,Neuropathy,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,tRNA-binding,	binding site:ATP,chain:Methionyl-tRNA synthetase, cytoplasmic,domain:GST C-terminal,domain:WHEP-TRS,helix,modified residue,sequence conflict,sequence variant,short sequence motif:"HIGH" region,short sequence motif:"KMSKS" region,strand,
142678	mindbomb E3 ubiquitin protein ligase 2(MIB2)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0007219~Notch signaling pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,	GO:0003779~actin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000433:Zinc finger, ZZ-type,IPR001841:Zinc finger, RING-type,IPR002110:Ankyrin repeat,IPR010606:Mib-herc2,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR020683:Ankyrin repeat-containing domain,				SM00184:RING,SM00248:ANK,SM00291:ZnF_ZZ,	Acetylation,Actin-binding,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Endosome,Ligase,Metal-binding,Notch signaling pathway,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase MIB2,domain:MIB/HERC2 1,domain:MIB/HERC2 2,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type 1,zinc finger region:RING-type 2,zinc finger region:ZZ-type,
8888	minichromosome maintenance complex component 3 associated protein(MCM3AP)	Homo sapiens				GO:0002376~immune system process,GO:0006260~DNA replication,GO:0006606~protein import into nucleus,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0016746~transferase activity, transferring acyl groups,	IPR005062:SAC3/GANP/Nin1/mts3/eIF-3 p25,IPR012677:Nucleotide-binding, alpha-beta plait,					3D-structure,Acetylation,Acyltransferase,Alternative promoter usage,Coiled coil,Complete proteome,Cytoplasm,Immunity,Membrane,Methylation,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transferase,Translocation,Transmembrane,Transmembrane helix,Transport,	chain:80 kDa MCM3-associated protein,modified residue,sequence variant,
55052	mitochondrial ribosomal protein L20(MRPL20)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005761~mitochondrial ribosome,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR005813:Ribosomal protein L20,	hsa03010:Ribosome,				3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L20, mitochondrial,transit peptide:Mitochondrion,
4216	mitogen-activated protein kinase kinase kinase 4(MAP3K4)	Homo sapiens	100.MAPK_signaling_cascades,	h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0001890~placenta development,GO:0010225~response to UV-C,GO:0010468~regulation of gene expression,GO:0019100~male germ-line sex determination,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0035556~intracellular signal transduction,GO:0043507~positive regulation of JUN kinase activity,GO:0051973~positive regulation of telomerase activity,GO:0060718~chorionic trophoblast cell differentiation,GO:1900745~positive regulation of p38MAPK cascade,GO:1904355~positive regulation of telomere capping,	GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04912:GnRH signaling pathway,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase 4,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
4629	myosin heavy chain 11(MYH11)	Homo sapiens				GO:0006936~muscle contraction,GO:0006939~smooth muscle contraction,GO:0030241~skeletal muscle myosin thick filament assembly,GO:0048251~elastic fiber assembly,GO:0048739~cardiac muscle fiber development,	GO:0005829~cytosol,GO:0005859~muscle myosin complex,GO:0016459~myosin complex,GO:0032982~myosin filament,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0003774~motor activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008307~structural constituent of muscle,GO:0051015~actin filament binding,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR002928:Myosin tail,IPR004009:Myosin, N-terminal, SH3-like,IPR008989:Myosin S1 fragment, N-terminal,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04530:Tight junction,	132900~Aortic aneurysm, familial thoracic 4,		SM00015:IQ,SM00242:MYSc,	Actin-binding,Alternative splicing,Aortic aneurysm,ATP-binding,Calmodulin-binding,Chromosomal rearrangement,Coiled coil,Complete proteome,Disease mutation,Methylation,Motor protein,Muscle protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Thick filament,	chain:Myosin-11,domain:IQ,domain:Myosin head-like,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Actin-binding,region of interest:Carboxyl-terminal,sequence conflict,sequence variant,
29781	non-SMC condensin II complex subunit H2(NCAPH2)	Homo sapiens				GO:0030261~chromosome condensation,GO:0051276~chromosome organization,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016020~membrane,	GO:0005515~protein binding,	IPR009378:Non-SMC condensin II complex, subunit H2-like,					Alternative splicing,Chromosome,Complete proteome,DNA condensation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Condensin-2 complex subunit H2,modified residue,sequence conflict,splice variant,
4926	nuclear mitotic apparatus protein 1(NUMA1)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_ranMSPathway:Role of Ran in mitotic spindle regulation,		GO:0000132~establishment of mitotic spindle orientation,GO:0006997~nucleus organization,GO:0007067~mitotic nuclear division,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0060487~lung epithelial cell differentiation,	GO:0000139~Golgi membrane,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0005938~cell cortex,GO:0016363~nuclear matrix,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045177~apical part of cell,GO:0061673~mitotic spindle astral microtubule,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,GO:0097431~mitotic spindle pole,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0008017~microtubule binding,	IPR026650:Golgin subfamily A member 3,		612376~Leukemia, acute promyelocytic, somatic,			3D-structure,Acetylation,ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Glycoprotein,Isopeptide bond,Microtubule,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Nuclear mitotic apparatus protein 1,modified residue,sequence conflict,sequence variant,splice variant,
9970	nuclear receptor subfamily 1 group I member 3(NR1I3)	Homo sapiens		h_acetaminophenPathway:Mechanism of Acetaminophen Activity and Toxicity,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0030521~androgen receptor signaling pathway,GO:0043401~steroid hormone mediated signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003713~transcription coactivator activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004882~androgen receptor activity,GO:0004887~thyroid hormone receptor activity,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR001728:Thyroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,				SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 1 group I member 3,DNA-binding region:Nuclear receptor,helix,sequence variant,splice variant,strand,turn,zinc finger region:NR C4-type,
51686	ornithine decarboxylase antizyme 3(OAZ3)	Homo sapiens				GO:0006521~regulation of cellular amino acid metabolic process,GO:0006595~polyamine metabolic process,GO:0006596~polyamine biosynthetic process,GO:0007283~spermatogenesis,GO:0015847~putrescine transport,GO:0043086~negative regulation of catalytic activity,GO:0045732~positive regulation of protein catabolic process,GO:1902268~negative regulation of polyamine transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008073~ornithine decarboxylase inhibitor activity,GO:0015489~putrescine transmembrane transporter activity,	IPR002993:Ornithine decarboxylase antizyme,IPR016181:Acyl-CoA N-acyltransferase,					Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polyamine biosynthesis,Proteomics identification,Reference proteome,Ribosomal frameshifting,	chain:Ornithine decarboxylase antizyme 3,
5480	peptidylprolyl isomerase C(PPIC)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016018~cyclosporin A binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,					3D-structure,Complete proteome,Cyclosporin,Cytoplasm,Isomerase,Polymorphism,Reference proteome,Rotamase,	chain:Peptidyl-prolyl cis-trans isomerase C,domain:PPIase cyclophilin-type,helix,sequence variant,strand,turn,
51535	periphilin 1(PPHLN1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031424~keratinization,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,						Acetylation,Alternative splicing,Chromosome,Complete proteome,Cytoplasm,Isopeptide bond,Keratinization,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Periphilin-1,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
10336	polycomb group ring finger 3(PCGF3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0016021~integral component of membrane,GO:0031519~PcG protein complex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,	hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00184:RING,	Alternative splicing,Complete proteome,Membrane,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Polycomb group RING finger protein 3,splice variant,zinc finger region:RING-type,
27039	polycystin 2 like 2, transient receptor potential cation channel(PKD2L2)	Homo sapiens				GO:0050982~detection of mechanical stimulus,GO:0070588~calcium ion transmembrane transport,	GO:0016021~integral component of membrane,	GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,	IPR003915:Polycystic kidney disease type 2 protein,IPR013122:Polycystin cation channel, PKD1/PKD2,					Alternative splicing,Coiled coil,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Polycystic kidney disease 2-like 2 protein,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Polycystin motif,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
26121	pre-mRNA processing factor 31(PRPF31)	Homo sapiens				GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0048254~snoRNA localization,GO:0071166~ribonucleoprotein complex localization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005687~U4 snRNP,GO:0005690~U4atac snRNP,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071339~MLL1 complex,	GO:0005515~protein binding,GO:0030621~U4 snRNA binding,GO:0030622~U4atac snRNA binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070990~snRNP binding,	IPR002687:Nop domain,IPR012976:NOSIC,IPR019175:Prp31 C-terminal,IPR027105:U4/U6 small nuclear ribonucleoprotein Prp31,	hsa03040:Spliceosome,	600138~Retinitis pigmentosa 11,		SM00931:SM00931,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Retinitis pigmentosa,Ribonucleoprotein,RNA-binding,Spliceosome,Viral nucleoprotein,Virion,	chain:U4/U6 small nuclear ribonucleoprotein Prp31,compositionally biased region:Poly-Glu,domain:Nop,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,site:Interaction with U4 snRNA,splice variant,turn,
10015	programmed cell death 6 interacting protein(PDCD6IP)	Homo sapiens				GO:0000920~cell separation after cytokinesis,GO:0006915~apoptotic process,GO:0006997~nucleus organization,GO:0007049~cell cycle,GO:0007080~mitotic metaphase plate congression,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0019058~viral life cycle,GO:0036258~multivesicular body assembly,GO:0039702~viral budding via host ESCRT complex,GO:0090611~ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,GO:1901673~regulation of mitotic spindle assembly,GO:1903543~positive regulation of exosomal secretion,GO:1903551~regulation of extracellular exosome assembly,GO:1903553~positive regulation of extracellular exosome assembly,	GO:0001772~immunological synapse,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0070971~endoplasmic reticulum exit site,GO:1903561~extracellular vesicle,	GO:0005515~protein binding,GO:0031871~proteinase activated receptor binding,GO:0042803~protein homodimerization activity,GO:0048306~calcium-dependent protein binding,	IPR004328:BRO1 domain,IPR025304:ALIX V-shaped domain,	hsa04144:Endocytosis,			SM01041:SM01041,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Host-virus interaction,Methylation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Secreted,Transport,	chain:Programmed cell death 6-interacting protein,compositionally biased region:Pro-rich,domain:BRO1,helix,modified residue,mutagenesis site,region of interest:Essential to promote virus budding,region of interest:Interaction with CEP55,region of interest:Interaction with CHMP4A, CHMP4B and CHMP4C,region of interest:Interaction with EIAV p9,region of interest:Interaction with TSG101,region of interest:Self-association,sequence conflict,sequence variant,strand,turn,
389333	proline rich basic protein 1(PROB1)	Homo sapiens												Complete proteome,Reference proteome,
23215	proline rich coiled-coil 2C(PRRC2C)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,	GO:0016020~membrane,	GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR009738:BAT2, N-terminal,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:BAT2 domain-containing protein 1,compositionally biased region:Ala-rich,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,
53635	prostate tumor overexpressed 1(PTOV1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,		IPR021394:Mediator complex, subunit Med25, PTOV activation and synapsin 2,					Activator,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Prostate tumor overexpressed gene 1 protein,region of interest:Interaction with FLOT1,splice variant,
11098	protease, serine 23(PRSS23)	Homo sapiens				GO:0006508~proteolysis,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,					Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,	active site:Charge relay system,chain:Serine protease 23,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
10213	proteasome 26S subunit, non-ATPase 14(PSMD14)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0000724~double-strand break repair via homologous recombination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006521~regulation of cellular amino acid metabolic process,GO:0010950~positive regulation of endopeptidase activity,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0045471~response to ethanol,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0061136~regulation of proteasomal protein catabolic process,GO:0070536~protein K63-linked deubiquitination,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0008541~proteasome regulatory particle, lid subcomplex,GO:0022624~proteasome accessory complex,GO:0031597~cytosolic proteasome complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,GO:0061133~endopeptidase activator activity,GO:0070628~proteasome binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR024969:Rpn11/EIF3F C-terminal domain,	hsa03050:Proteasome,hsa05169:Epstein-Barr virus infection,			SM00232:JAB_MPN,	3D-structure,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Hydrolase,Metal-binding,Metalloprotease,Phosphoprotein,Protease,Proteasome,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,	chain:26S proteasome non-ATPase regulatory subunit 14,domain:MPN,metal ion-binding site:Zinc; catalytic,modified residue,short sequence motif:JAMM motif,
5713	proteasome 26S subunit, non-ATPase 7(PSMD7)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006521~regulation of cellular amino acid metabolic process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005838~proteasome regulatory particle,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR024969:Rpn11/EIF3F C-terminal domain,	hsa03050:Proteasome,hsa05169:Epstein-Barr virus infection,			SM00232:JAB_MPN,	3D-structure,Acetylation,Complete proteome,Isopeptide bond,Proteasome,Proteomics identification,Reference proteome,Ubl conjugation,	chain:26S proteasome non-ATPase regulatory subunit 7,compositionally biased region:Glu/Lys-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:MPN,helix,modified residue,sequence conflict,strand,turn,
5695	proteasome subunit beta 7(PSMB7)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006521~regulation of cellular amino acid metabolic process,GO:0016032~viral process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043488~regulation of mRNA stability,GO:0050852~T cell receptor signaling pathway,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0070062~extracellular exosome,	GO:0004298~threonine-type endopeptidase activity,GO:0005515~protein binding,	IPR000243:Peptidase T1A, proteasome beta-subunit,IPR001353:Proteasome, subunit alpha/beta,IPR016050:Proteasome, beta-type subunit, conserved site,IPR023333:Proteasome B-type subunit,IPR024689:Proteasome beta subunit, C-terminal,	hsa03050:Proteasome,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Hydrolase,Nucleus,Polymorphism,Protease,Proteasome,Proteomics identification,Reference proteome,Threonine protease,Zymogen,	active site:Nucleophile,chain:Proteasome subunit beta type-7,modified residue,propeptide:Removed in mature form,sequence variant,
5590	protein kinase C zeta(PRKCZ)	Homo sapiens		h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0000226~microtubule cytoskeleton organization,GO:0001954~positive regulation of cell-matrix adhesion,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007616~long-term memory,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0016477~cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0030010~establishment of cell polarity,GO:0031333~negative regulation of protein complex assembly,GO:0031532~actin cytoskeleton reorganization,GO:0031584~activation of phospholipase D activity,GO:0032148~activation of protein kinase B activity,GO:0032753~positive regulation of interleukin-4 production,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0046326~positive regulation of glucose import,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0047496~vesicle transport along microtubule,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051291~protein heterooligomerization,GO:0051346~negative regulation of hydrolase activity,GO:0051899~membrane depolarization,GO:0060081~membrane hyperpolarization,GO:0060291~long-term synaptic potentiation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070528~protein kinase C signaling,GO:0072659~protein localization to plasma membrane,GO:1990138~neuron projection extension,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,GO:2001181~positive regulation of interleukin-10 secretion,	GO:0005622~intracellular,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0031252~cell leading edge,GO:0031941~filamentous actin,GO:0031982~vesicle,GO:0035748~myelin sheath abaxonal region,GO:0043203~axon hillock,GO:0045121~membrane raft,GO:0045179~apical cortex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015459~potassium channel regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0043274~phospholipase binding,GO:0043560~insulin receptor substrate binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000270:Phox/Bem1p,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR012233:Protein kinase C, zeta/iota,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,IPR020454:Diacylglycerol/phorbol-ester binding,	hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04390:Hippo signaling pathway,hsa04530:Tight junction,hsa04611:Platelet activation,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,		PIRSF000554:protein kinase C, zeta/iota types,	SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00666:PB1,	Alternative splicing,ATP-binding,Cell junction,Complete proteome,Cytoplasm,Endosome,Inflammatory response,Kinase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Protein kinase C zeta type,domain:AGC-kinase C-terminal,domain:OPR,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with SQSTM1,sequence conflict,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
5499	protein phosphatase 1 catalytic subunit alpha(PPP1CA)	Homo sapiens		h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics,h_akapcentrosomePathway:Protein Kinase A at the Centrosome,h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors,h_eif2Pathway:Regulation of eIF2,		GO:0005977~glycogen metabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,GO:0006470~protein dephosphorylation,GO:0007049~cell cycle,GO:0016311~dephosphorylation,GO:0030324~lung development,GO:0032091~negative regulation of protein binding,GO:0032922~circadian regulation of gene expression,GO:0036496~regulation of translational initiation by eIF2 alpha dephosphorylation,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051301~cell division,GO:0060828~regulation of canonical Wnt signaling pathway,GO:1904886~beta-catenin destruction complex disassembly,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0000164~protein phosphatase type 1 complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0042587~glycogen granule,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0070062~extracellular exosome,GO:0070688~MLL5-L complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,GO:0016791~phosphatase activity,GO:0032403~protein complex binding,GO:0043021~ribonucleoprotein complex binding,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,IPR006311:Twin-arginine translocation pathway, signal sequence,	hsa03015:mRNA surveillance pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04390:Hippo signaling pathway,hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04720:Long-term potentiation,hsa04728:Dopaminergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04931:Insulin resistance,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05168:Herpes simplex infection,hsa05205:Proteoglycans in cancer,			SM00156:PP2Ac,	3D-structure,Acetylation,Alternative splicing,Carbohydrate metabolism,Cell cycle,Cell division,Complete proteome,Cytoplasm,Direct protein sequencing,Glycogen metabolism,Hydrolase,Manganese,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Proton donor,chain:Serine/threonine-protein phosphatase PP1- alpha catalytic subunit,helix,metal ion-binding site:Iron,metal ion-binding site:Manganese,modified residue,strand,turn,
11079	retention in endoplasmic reticulum sorting receptor 1(RER1)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,	GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,	GO:0033130~acetylcholine receptor binding,	IPR004932:Retrieval of early ER protein Rer1,			PIRSF016013:endoplasmic reticulum retrieval protein, Rer1p type,		Acetylation,Complete proteome,Golgi apparatus,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein RER1,modified residue,sequence conflict,transmembrane region,
84153	ribonuclease H2 subunit C(RNASEH2C)	Homo sapiens				GO:0006401~RNA catabolic process,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005634~nucleus,GO:0032299~ribonuclease H2 complex,	GO:0004523~RNA-DNA hybrid ribonuclease activity,	IPR013924:Ribonuclease H2, subunit C,	hsa03030:DNA replication,	610329~Aicardi-Goutieres syndrome 3,			3D-structure,Acetylation,Aicardi-Goutieres syndrome,Alternative splicing,Complete proteome,Disease mutation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Ribonuclease H2 subunit C,modified residue,sequence variant,splice variant,
6238	ribosome binding protein 1(RRBP1)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005840~ribosome,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0004872~receptor activity,GO:0044822~poly(A) RNA binding,	IPR007794:Ribosome receptor lysine/proline rich,	hsa04141:Protein processing in endoplasmic reticulum,				Acetylation,Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Receptor,Reference proteome,Repeat,Translocation,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Ribosome-binding protein 1,modified residue,region of interest:41 X 10 AA approximate tandem repeats of [TN]-Q-[GSA]-[KRQT]-K-[ATGSV]-[ED]- [GTAS]-[ATIS]-[PQTAS],repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33,repeat:34; approximate,repeat:35,repeat:36; approximate,repeat:37,repeat:38,repeat:39; approximate,repeat:4,repeat:40,repeat:41,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
114804	ring finger protein 157(RNF157)	Homo sapiens						GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Alternative splicing,Complete proteome,Lipoprotein,Metal-binding,Myristate,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:RING finger protein 157,compositionally biased region:Ser-rich,sequence variant,splice variant,zinc finger region:RING-type,
140545	ring finger protein 32(RNF32)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,		GO:0005768~endosome,GO:0016235~aggresome,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000048:IQ motif, EF-hand binding site,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,	Alternative splicing,Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:RING finger protein 32,domain:IQ,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type 1; atypical,zinc finger region:RING-type 2; atypical,
8878	sequestosome 1(SQSTM1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000422~mitophagy,GO:0001934~positive regulation of protein phosphorylation,GO:0002376~immune system process,GO:0006468~protein phosphorylation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006950~response to stress,GO:0008104~protein localization,GO:0010821~regulation of mitochondrion organization,GO:0016197~endosomal transport,GO:0016236~macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0030154~cell differentiation,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044130~negative regulation of growth of symbiont in host,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046578~regulation of Ras protein signal transduction,GO:0051291~protein heterooligomerization,GO:0061635~regulation of protein complex stability,GO:0098779~mitophagy in response to mitochondrial depolarization,	GO:0000407~pre-autophagosomal structure,GO:0000932~cytoplasmic mRNA processing body,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016234~inclusion body,GO:0016235~aggresome,GO:0016605~PML body,GO:0031410~cytoplasmic vesicle,GO:0044753~amphisome,GO:0044754~autolysosome,GO:0070062~extracellular exosome,GO:0097225~sperm midpiece,	GO:0004674~protein serine/threonine kinase activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042169~SH2 domain binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043130~ubiquitin binding,GO:0070530~K63-linked polyubiquitin binding,	IPR000270:Phox/Bem1p,IPR000433:Zinc finger, ZZ-type,IPR009060:UBA-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,	hsa04380:Osteoclast differentiation,	167250~Paget disease of bone 3,616437~Frontotemporal dementia and/or amyotrophic lateral sclerosis 3,		SM00165:UBA,SM00291:ZnF_ZZ,SM00666:PB1,	3D-structure,Acetylation,Alternative splicing,Amyotrophic lateral sclerosis,Apoptosis,Autophagy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Differentiation,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,Endosome,Immunity,Lysosome,Metal-binding,Neurodegeneration,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Sequestosome-1,compositionally biased region:Ser-rich,domain:OPR,domain:UBA,helix,modified residue,mutagenesis site,region of interest:Interaction with GABRR3,region of interest:Interaction with LCK,region of interest:Interaction with NTRK1,region of interest:Interaction with PAWR,region of interest:Interaction with PRKCZ and dimerization,region of interest:LIM protein-binding (LB),sequence conflict,sequence variant,short sequence motif:TRAF6-binding,splice variant,turn,zinc finger region:ZZ-type,
253190	serine hydrolase-like 2(SERHL2)	Homo sapiens					GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0016787~hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,					Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Peroxisome,Polymorphism,Reference proteome,	chain:Serine hydrolase-like protein 2,sequence variant,splice variant,
63826	serine racemase(SRR)	Homo sapiens			Amino acid transport and metabolism,	GO:0006520~cellular amino acid metabolic process,GO:0006563~L-serine metabolic process,GO:0007420~brain development,GO:0007568~aging,GO:0009069~serine family amino acid metabolic process,GO:0032496~response to lipopolysaccharide,GO:0042493~response to drug,GO:0042866~pyruvate biosynthetic process,GO:0043278~response to morphine,GO:0051289~protein homotetramerization,GO:0070178~D-serine metabolic process,GO:0070179~D-serine biosynthetic process,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0043025~neuronal cell body,GO:0045177~apical part of cell,	GO:0000287~magnesium ion binding,GO:0003941~L-serine ammonia-lyase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008721~D-serine ammonia-lyase activity,GO:0016594~glycine binding,GO:0018114~threonine racemase activity,GO:0030165~PDZ domain binding,GO:0030170~pyridoxal phosphate binding,GO:0030378~serine racemase activity,GO:0042803~protein homodimerization activity,	IPR000634:Serine/threonine dehydratase, pyridoxal-phosphate-binding site,IPR001926:Tryptophan synthase beta subunit-like PLP-dependent enzymes superfamily,	hsa00260:Glycine, serine and threonine metabolism,				3D-structure,Allosteric enzyme,ATP-binding,Complete proteome,Direct protein sequencing,Isomerase,Lyase,Magnesium,Metal-binding,Nucleotide-binding,Proteomics identification,Pyridoxal phosphate,Reference proteome,S-nitrosylation,	active site:Catalytic base,chain:Serine racemase,metal ion-binding site:Magnesium,modified residue,
6477	siah E3 ubiquitin protein ligase 1(SIAH1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0009653~anatomical structure morphogenesis,GO:0030163~protein catabolic process,GO:0031648~protein destabilization,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0044267~cellular protein metabolic process,GO:0051402~neuron apoptotic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030877~beta-catenin destruction complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0042802~identical protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR004162:Seven-in-absentia protein, sina,IPR008974:TRAF-like,IPR013010:Zinc finger, SIAH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013323:SIAH-type domain,IPR018121:Seven-in-absentia protein, TRAF-like domain,	hsa04115:p53 signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04310:Wnt signaling pathway,				3D-structure,Alternative splicing,Apoptosis,Cell cycle,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Spermatogenesis,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase SIAH1,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,mutagenesis site,region of interest:SBD,sequence conflict,splice variant,strand,turn,zinc finger region:RING-type,zinc finger region:SIAH-type,
11066	small nuclear ribonucleoprotein U11/U12 subunit 35(SNRNP35)	Homo sapiens			Defense mechanisms,	GO:0000398~mRNA splicing, via spliceosome,GO:0008380~RNA splicing,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005689~U12-type spliceosomal complex,GO:0071011~precatalytic spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0017069~snRNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Reference proteome,RNA-binding,Spliceosome,	chain:ATP-binding cassette sub-family B member 5,chain:U11/U12 small nuclear ribonucleoprotein 35 kDa protein,compositionally biased region:Arg-rich,domain:ABC transmembrane type-1,domain:ABC transporter 1,domain:ABC transporter 2,domain:RRM,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
51296	solute carrier family 15 member 3(SLC15A3)	Homo sapiens			Amino acid transport and metabolism,	GO:0006811~ion transport,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0015992~proton transport,GO:0055085~transmembrane transport,	GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0015333~peptide:proton symporter activity,	IPR000109:Proton-dependent oligopeptide transporter family,IPR020846:Major facilitator superfamily domain,					Complete proteome,Glycoprotein,Lysosome,Membrane,Peptide transport,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 15 member 3,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Val,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
81034	solute carrier family 25 member 32(SLC25A32)	Homo sapiens				GO:0006412~translation,GO:0006544~glycine metabolic process,GO:0006810~transport,GO:0006839~mitochondrial transport,GO:0015884~folic acid transport,GO:0046655~folic acid metabolic process,GO:1904947~folic acid import into mitochondrion,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0003735~structural constituent of ribosome,GO:0008517~folic acid transporter activity,	IPR002030:Mitochondrial brown fat uncoupling protein,IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Mitochondrial folate transporter/carrier,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,sequence variant,transmembrane region,
10861	solute carrier family 26 member 1(SLC26A1)	Homo sapiens				GO:0006811~ion transport,GO:0006821~chloride transport,GO:0008272~sulfate transport,GO:0015701~bicarbonate transport,GO:0019532~oxalate transport,GO:0042391~regulation of membrane potential,GO:0044255~cellular lipid metabolic process,GO:0050428~3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,GO:0051453~regulation of intracellular pH,GO:1902358~sulfate transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005254~chloride channel activity,GO:0008271~secondary active sulfate transmembrane transporter activity,GO:0008374~O-acyltransferase activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015108~chloride transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015301~anion:anion antiporter activity,GO:0019531~oxalate transmembrane transporter activity,	IPR001902:Sulphate anion transporter,IPR002645:STAS domain,IPR011547:Sulphate transporter,IPR018045:Sulphate anion transporter, conserved site,IPR022284:Glycerol-3-phosphate O-acyltransferase,					Alternative splicing,Anion exchange,Antiport,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Sulfate anion transporter 1,domain:STAS,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
10998	solute carrier family 27 member 5(SLC27A5)	Homo sapiens				GO:0000038~very long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0006642~triglyceride mobilization,GO:0006699~bile acid biosynthetic process,GO:0015721~bile acid and bile salt transport,GO:0015911~plasma membrane long-chain fatty acid transport,GO:0046951~ketone body biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0009925~basal plasma membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0043234~protein complex,	GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005524~ATP binding,GO:0015245~fatty acid transporter activity,GO:0031957~very long-chain fatty acid-CoA ligase activity,GO:0032403~protein complex binding,GO:0047747~cholate-CoA ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR020845:AMP-binding, conserved site,IPR025110:Domain of unknown function DUF4009,	hsa00120:Primary bile acid biosynthesis,hsa01100:Metabolic pathways,hsa03320:PPAR signaling pathway,hsa04931:Insulin resistance,hsa04976:Bile secretion,				Alternative splicing,ATP-binding,Complete proteome,Endoplasmic reticulum,Fatty acid metabolism,Ligase,Lipid metabolism,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Bile acyl-CoA synthetase,nucleotide phosphate-binding region:AMP,sequence variant,topological domain:Cytoplasmic,transmembrane region,
124565	solute carrier family 38 member 10(SLC38A10)	Homo sapiens				GO:0003333~amino acid transmembrane transport,GO:0006814~sodium ion transport,GO:0060348~bone development,	GO:0016021~integral component of membrane,	GO:0015171~amino acid transmembrane transporter activity,	IPR013057:Amino acid transporter, transmembrane,					Alternative splicing,Amino-acid transport,Coiled coil,Complete proteome,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Putative sodium-coupled neutral amino acid transporter 10,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
55630	solute carrier family 39 member 4(SLC39A4)	Homo sapiens				GO:0006882~cellular zinc ion homeostasis,GO:0034224~cellular response to zinc ion starvation,GO:0071578~zinc II ion transmembrane import,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0005385~zinc ion transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,	IPR003689:Zinc/iron permease,	hsa04978:Mineral absorption,	201100~Acrodermatitis enteropathica,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Endosome,Glycoprotein,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc transport,	chain:Zinc transporter ZIP4,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
6524	solute carrier family 5 member 2(SLC5A2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006810~transport,GO:0006814~sodium ion transport,GO:0055085~transmembrane transport,GO:1904659~glucose transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005362~low-affinity glucose:sodium symporter activity,GO:0005412~glucose:sodium symporter activity,	IPR001734:Sodium/solute symporter,IPR018212:Sodium/solute symporter, conserved site,		233100~Renal glucosuria,			Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sugar transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/glucose cotransporter 2,glycosylation site:N-linked (GlcNAc...),sequence variant,site:Implicated in sodium coupling,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
84138	solute carrier family 7 member 6 opposite strand(SLC7A6OS)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR013883:Transcription factor  Iwr1,					Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Protein SLC7A6OS,modified residue,sequence conflict,sequence variant,
6550	solute carrier family 9 member A3(SLC9A3)	Homo sapiens				GO:0006811~ion transport,GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005903~brush border,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015299~solute:proton antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,GO:0030165~PDZ domain binding,	IPR004709:Na+/H+ exchanger,IPR006153:Cation/H+ exchanger,IPR018410:Na+/H+ exchanger, isoforms 3/5,IPR018422:Cation/H+ exchanger, CPA1 family,	hsa04964:Proximal tubule bicarbonate reclamation,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,				Alternative splicing,Antiport,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 3,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:A (M1) hydrophobic,region of interest:B (M2) hydrophobic,region of interest:Interaction with PDZD3,region of interest:L, hydrophobic,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
150159	solute carrier family 9 member B1(SLC9B1)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0015299~solute:proton antiporter activity,GO:0015385~sodium:proton antiporter activity,	IPR006153:Cation/H+ exchanger,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger-like domain- containing protein 1,sequence conflict,sequence variant,splice variant,transmembrane region,
9784	sorting nexin 17(SNX17)	Homo sapiens				GO:0003279~cardiac septum development,GO:0006707~cholesterol catabolic process,GO:0006886~intracellular protein transport,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0016197~endosomal transport,GO:0030100~regulation of endocytosis,GO:0035904~aorta development,GO:0060976~coronary vasculature development,GO:1990126~retrograde transport, endosome to plasma membrane,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0035091~phosphatidylinositol binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR000159:Ras-association,IPR001683:Phox homologous domain,				SM00312:PX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Endosome,Lipid-binding,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Sorting nexin-17,domain:PX,domain:Ras-associating,helix,modified residue,mutagenesis site,sequence conflict,strand,
79856	sorting nexin 22(SNX22)	Homo sapiens				GO:0015031~protein transport,	GO:0030659~cytoplasmic vesicle membrane,	GO:0035091~phosphatidylinositol binding,	IPR001683:Phox homologous domain,				SM00312:PX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasmic vesicle,Lipid-binding,Membrane,Protein transport,Reference proteome,Signal,Transport,	chain:Sorting nexin-22,domain:PX,helix,sequence conflict,strand,
6709	spectrin alpha, non-erythrocytic 1(SPTAN1)	Homo sapiens		h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0000165~MAPK cascade,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007010~cytoskeleton organization,GO:0007411~axon guidance,GO:0043547~positive regulation of GTPase activity,GO:0051693~actin filament capping,GO:0098609~cell-cell adhesion,	GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0008091~spectrin,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0003779~actin binding,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005200~structural constituent of cytoskeleton,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013315:Spectrin alpha chain, SH3 domain,IPR014837:EF-hand, Ca insensitive,IPR018159:Spectrin/alpha-actinin,IPR018247:EF-Hand 1, calcium-binding site,		613477~Epileptic encephalopathy, early infantile, 5,		SM00054:EFh,SM00150:SPEC,SM00326:SH3,	3D-structure,Acetylation,Actin capping,Actin-binding,Alternative splicing,Calcium,Calmodulin-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Epilepsy,Mental retardation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	calcium-binding region:1,calcium-binding region:2,chain:Spectrin alpha chain, brain,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:SH3,helix,modified residue,repeat:Spectrin 1,repeat:Spectrin 10,repeat:Spectrin 11,repeat:Spectrin 12,repeat:Spectrin 13,repeat:Spectrin 14,repeat:Spectrin 15,repeat:Spectrin 16,repeat:Spectrin 17,repeat:Spectrin 18,repeat:Spectrin 19,repeat:Spectrin 2,repeat:Spectrin 20,repeat:Spectrin 21,repeat:Spectrin 22,repeat:Spectrin 23,repeat:Spectrin 3,repeat:Spectrin 4,repeat:Spectrin 5,repeat:Spectrin 6,repeat:Spectrin 7,repeat:Spectrin 8,repeat:Spectrin 9,sequence conflict,sequence variant,site:Cleavage; by mu-calpain,splice variant,
124976	sphingolipid transporter 2(SPNS2)	Homo sapiens				GO:0001782~B cell homeostasis,GO:0002920~regulation of humoral immune response,GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0006665~sphingolipid metabolic process,GO:0006869~lipid transport,GO:0040011~locomotion,GO:0043029~T cell homeostasis,GO:0048073~regulation of eye pigmentation,GO:0048535~lymph node development,GO:0055085~transmembrane transport,GO:0060348~bone development,GO:0072676~lymphocyte migration,	GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,GO:0031982~vesicle,	GO:0046624~sphingolipid transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Complete proteome,Lipid transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Protein spinster homolog 2,mutagenesis site,sequence conflict,transmembrane region,
55627	sphingomyelin phosphodiesterase 4(SMPD4)	Homo sapiens				GO:0006685~sphingomyelin catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0046475~glycerophospholipid catabolic process,GO:0046513~ceramide biosynthetic process,GO:0071356~cellular response to tumor necrosis factor,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0016021~integral component of membrane,	GO:0004767~sphingomyelin phosphodiesterase activity,GO:0046872~metal ion binding,GO:0050290~sphingomyelin phosphodiesterase D activity,	IPR024129:Sphingomyelin phosphodiesterase 4,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Hydrolase,Magnesium,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sphingomyelin phosphodiesterase 4,modified residue,sequence conflict,splice variant,transmembrane region,
90864	splA/ryanodine receptor domain and SOCS box containing 3(SPSB3)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,	GO:0005515~protein binding,	IPR001496:SOCS protein, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00449:SPRY,SM00969:SM00969,	Complete proteome,Polymorphism,Proteomics identification,Receptor,Reference proteome,	chain:SPRY domain-containing SOCS box protein 3,domain:B30.2/SPRY,domain:SOCS box,sequence conflict,sequence variant,
140890	splicing regulatory glutamic acid and lysine rich protein 1(SREK1)	Homo sapiens				GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Spliceosome,	chain:Splicing factor, arginine/serine-rich 12,compositionally biased region:Arg/Glu/Lys/Ser-rich,domain:RRM,modified residue,splice variant,
8303	stannin(SNN)	Homo sapiens				GO:0006950~response to stress,GO:0009628~response to abiotic stimulus,	GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,		IPR015135:Stannin transmembrane,IPR015136:Stannin unstructured linker,IPR015137:Stannin cytoplasmic,IPR027435:Stannin,					3D-structure,Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Stannin,helix,modified residue,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,turn,
55206	strawberry notch homolog 1(SBNO1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,			IPR026741:Protein strawberry notch-like,IPR026937:Strawberry notch, helicase C domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Protein strawberry notch homolog 1,compositionally biased region:Poly-Lys,modified residue,sequence conflict,sequence variant,splice variant,
6853	synapsin I(SYN1)	Homo sapiens			Coenzyme metabolism / Translation, ribosomal structure and biogenesis,	GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0046928~regulation of neurotransmitter secretion,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0000795~synaptonemal complex,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0008021~synaptic vesicle,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0030672~synaptic vesicle membrane,GO:0043195~terminal bouton,GO:0043209~myelin sheath,GO:0048786~presynaptic active zone,	GO:0003779~actin binding,GO:0003824~catalytic activity,GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0048306~calcium-dependent protein binding,	IPR001359:Synapsin,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016185:Pre-ATP-grasp domain,IPR019735:Synapsin, conserved site,IPR019736:Synapsin, phosphorylation site,IPR020897:Synapsin, pre-ATP-grasp domain,IPR020898:Synapsin, ATP-binding domain,		300491~Epilepsy, X-linked, with variable learning disabilities and behavior disorders,			Actin-binding,Alternative splicing,Cell junction,Complete proteome,Epilepsy,Glycoprotein,Golgi apparatus,Methylation,Phosphoprotein,Reference proteome,Repeat,Synapse,	chain:Synapsin-1,glycosylation site:O-linked (GlcNAc),modified residue,region of interest:A,region of interest:B; linker,region of interest:C; actin-binding and synaptic-vesicle binding,region of interest:D; Pro-rich linker,region of interest:E,sequence conflict,splice variant,
83849	synaptotagmin 15(SYT15)	Homo sapiens				GO:0006906~vesicle fusion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0098793~presynapse,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,				SM00239:C2,	Alternative splicing,Cell membrane,Complete proteome,Membrane,Proteomics identification,Reference proteome,Repeat,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-15,domain:C2 1,domain:C2 2,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
64852	terminal uridylyl transferase 1, U6 snRNA-specific(TUT1)	Homo sapiens				GO:0006378~mRNA polyadenylation,GO:0016180~snRNA processing,GO:0071044~histone mRNA catabolic process,GO:0098789~pre-mRNA cleavage required for polyadenylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0016607~nuclear speck,GO:0045171~intercellular bridge,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0004652~polynucleotide adenylyltransferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0019899~enzyme binding,GO:0046872~metal ion binding,GO:0050265~RNA uridylyltransferase activity,	IPR000504:RNA recognition motif domain,IPR002058:PAP/25A-associated,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,ATP-binding,Complete proteome,Direct protein sequencing,Magnesium,Manganese,Metal-binding,mRNA processing,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transferase,Zinc,Zinc-finger,	chain:U6 snRNA-specific terminal uridylyltransferase 1,domain:RRM,helix,modified residue,sequence conflict,sequence variant,strand,
84817	thioredoxin domain containing 17(TXNDC17)	Homo sapiens				GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0055114~oxidation-reduction process,GO:0098869~cellular oxidant detoxification,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004601~peroxidase activity,GO:0005515~protein binding,GO:0047134~protein-disulfide reductase activity,	IPR010357:Protein of unknown function DUF953, thioredoxin-like,IPR012336:Thioredoxin-like fold,					3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Proteomics identification,Redox-active center,Reference proteome,	active site:Nucleophile,chain:Thioredoxin domain-containing protein 17,disulfide bond,domain:Thioredoxin,helix,modified residue,mutagenesis site,site:Contributes to redox potential value,strand,turn,
10190	thioredoxin domain containing 9(TXNDC9)	Homo sapiens				GO:0008616~queuosine biosynthetic process,GO:0045454~cell redox homeostasis,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005913~cell-cell adherens junction,GO:0030496~midbody,	GO:0005515~protein binding,GO:0008479~queuine tRNA-ribosyltransferase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Thioredoxin domain-containing protein 9,domain:Thioredoxin,modified residue,sequence conflict,sequence variant,
7298	thymidylate synthetase(TYMS)	Homo sapiens	1.RBphosphoE2F,			GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006139~nucleobase-containing compound metabolic process,GO:0006231~dTMP biosynthetic process,GO:0006235~dTTP biosynthetic process,GO:0006417~regulation of translation,GO:0007568~aging,GO:0007623~circadian rhythm,GO:0008283~cell proliferation,GO:0009157~deoxyribonucleoside monophosphate biosynthetic process,GO:0009636~response to toxic substance,GO:0016049~cell growth,GO:0019088~immortalization of host cell by virus,GO:0019860~uracil metabolic process,GO:0032259~methylation,GO:0032570~response to progesterone,GO:0033189~response to vitamin A,GO:0034097~response to cytokine,GO:0035999~tetrahydrofolate interconversion,GO:0042493~response to drug,GO:0045471~response to ethanol,GO:0046078~dUMP metabolic process,GO:0046134~pyrimidine nucleoside biosynthetic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046683~response to organophosphorus,GO:0048589~developmental growth,GO:0051216~cartilage development,GO:0051384~response to glucocorticoid,GO:0051593~response to folic acid,GO:0060574~intestinal epithelial cell maturation,GO:0071897~DNA biosynthetic process,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003729~mRNA binding,GO:0004799~thymidylate synthase activity,GO:0005542~folic acid binding,GO:0008144~drug binding,GO:0042803~protein homodimerization activity,GO:0048037~cofactor binding,	IPR000398:Thymidylate synthase,IPR020940:Thymidylate synthase, active site,IPR023451:Thymidylate synthase/dCMP hydroxymethylase domain,	hsa00240:Pyrimidine metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Methyltransferase,Mitochondrion,Mitochondrion inner membrane,Nucleotide biosynthesis,Nucleus,Phosphoprotein,Reference proteome,Transferase,	chain:Thymidylate synthase,helix,modified residue,strand,turn,
7112	thymopoietin(TMPO)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0098609~cell-cell adhesion,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0005521~lamin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003887:LEM domain,IPR011015:LEM/LEM-like domain,IPR013146:LEM-like domain,IPR021623:Lamina-associated polypeptide 2 alpha,		613740~Cardiomyopathy, dilated, 1T,		SM00540:LEM,SM01261:SM01261,	3D-structure,Acetylation,Alternative splicing,Cardiomyopathy,Chromosome,Citrullination,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Membrane,Methylation,Nucleus,Pharmaceutical,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Lamina-associated polypeptide 2, isoform alpha,chain:Lamina-associated polypeptide 2, isoforms beta/gamma,domain:LEM,domain:LEM-like,helix,modified residue,peptide:Thymopentin,peptide:Thymopoietin,region of interest:Binds lamins B,region of interest:Linker,region of interest:NAKAP95-binding C,region of interest:NAKAP95-binding N,region of interest:Nucleoplasmic,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,topological domain:Lumenal,transmembrane region,turn,
11011	tousled like kinase 2(TLK2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0001672~regulation of chromatin assembly or disassembly,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0010507~negative regulation of autophagy,GO:0016569~covalent chromatin modification,GO:0018105~peptidyl-serine phosphorylation,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0035556~intracellular signal transduction,GO:0071480~cellular response to gamma radiation,	GO:0005634~nucleus,GO:0005882~intermediate filament,GO:0030054~cell junction,GO:0048471~perinuclear region of cytoplasm,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR027086:Serine/threonine-protein kinase TOUSLED-like,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell cycle,Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase tousled- like 2,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
51106	transcription factor B1, mitochondrial(TFB1M)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007005~mitochondrion organization,GO:0031167~rRNA methylation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,	GO:0000179~rRNA (adenine-N6,N6-)-dimethyltransferase activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001737:Ribosomal RNA adenine methylase transferase,IPR011530:Ribosomal RNA adenine dimethylase,IPR020596:Ribosomal RNA adenine methylase transferase, conserved site,IPR020598:Ribosomal RNA adenine methylase transferase, N-terminal,IPR023165:rRNA adenine dimethylase-like,				SM00650:rADc,	Complete proteome,DNA-binding,Methyltransferase,Mitochondrion,Polymorphism,Reference proteome,RNA-binding,rRNA processing,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Transit peptide,	chain:Dimethyladenosine transferase 1, mitochondrial,mutagenesis site,sequence conflict,transit peptide:Mitochondrion,
10452	translocase of outer mitochondrial membrane 40(TOMM40)	Homo sapiens				GO:0006626~protein targeting to mitochondrion,GO:0006811~ion transport,GO:0016236~macroautophagy,GO:0030150~protein import into mitochondrial matrix,GO:0055085~transmembrane transport,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0016021~integral component of membrane,GO:0031307~integral component of mitochondrial outer membrane,GO:0046930~pore complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008320~protein transmembrane transporter activity,GO:0015266~protein channel activity,GO:0015288~porin activity,	IPR023614:Porin domain,IPR027246:Eukaryotic porin/Tom40,	hsa05014:Amyotrophic lateral sclerosis (ALS),				Alternative splicing,Complete proteome,Direct protein sequencing,Ion transport,Membrane,Mitochondrion,Mitochondrion outer membrane,Porin,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane beta strand,Transport,	chain:Mitochondrial import receptor subunit TOM40 homolog,compositionally biased region:Pro-rich,sequence conflict,splice variant,
11018	transmembrane p24 trafficking protein 1(TMED1)	Homo sapiens				GO:0006810~transport,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR009038:GOLD,IPR015720:TMP21-related,				SM01190:SM01190,	Cell membrane,Coiled coil,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Golgi apparatus,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane emp24 domain-containing protein 1,domain:GOLD,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
144404	transmembrane protein 120B(TMEM120B)	Homo sapiens				GO:0045444~fat cell differentiation,GO:0051291~protein heterooligomerization,	GO:0005637~nuclear inner membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR012926:TMPIT-like,					Coiled coil,Complete proteome,Membrane,Nucleus,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 120B,sequence conflict,transmembrane region,
55281	transmembrane protein 140(TMEM140)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 140,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
374395	transmembrane protein 179B(TMEM179B)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 179B,modified residue,transmembrane region,
10352	tryptophanyl tRNA synthetase 2, mitochondrial(WARS2)	Homo sapiens				GO:0001570~vasculogenesis,GO:0006418~tRNA aminoacylation for protein translation,GO:0006436~tryptophanyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,	GO:0004830~tryptophan-tRNA ligase activity,GO:0005524~ATP binding,	IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002305:Aminoacyl-tRNA synthetase, class Ic,IPR002306:Tryptophan-tRNA ligase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR024109:Tryptophan-tRNA ligase, bacterial-type,	hsa00970:Aminoacyl-tRNA biosynthesis,				Alternative splicing,Aminoacyl-tRNA synthetase,ATP-binding,Complete proteome,Ligase,Mitochondrion,Nucleotide-binding,Polymorphism,Protein biosynthesis,Reference proteome,Transit peptide,	chain:Tryptophanyl-tRNA synthetase, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
84617	tubulin beta 6 class V(TUBB6)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002453:Beta tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR008280:Tubulin/FtsZ, C-terminal,IPR013838:Beta tubulin, autoregulation binding site,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	hsa04145:Phagosome,hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,			SM00864:SM00864,SM00865:SM00865,	Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Isopeptide bond,Microtubule,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Tubulin beta-6 chain,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
11076	tubulin polymerization promoting protein(TPPP)	Homo sapiens				GO:0001578~microtubule bundle formation,GO:0031334~positive regulation of protein complex assembly,GO:0032273~positive regulation of protein polymerization,GO:0046785~microtubule polymerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,	IPR008907:P25-alpha,IPR011992:EF-hand-like domain,					Complete proteome,Cytoplasm,Cytoskeleton,Glycoprotein,Nucleus,Phosphoprotein,Reference proteome,	chain:Tubulin polymerization-promoting protein,glycosylation site:O-linked (GlcNAc),modified residue,region of interest:Mediates interaction with LIMK1,
24144	tuftelin interacting protein 11(TFIP11)	Homo sapiens				GO:0000390~spliceosomal complex disassembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0031214~biomineral tissue development,GO:0031333~negative regulation of protein complex assembly,GO:0031848~protection from non-homologous end joining at telomere,GO:0032091~negative regulation of protein binding,GO:1904876~negative regulation of DNA ligase activity,GO:2001033~negative regulation of double-strand break repair via nonhomologous end joining,	GO:0000784~nuclear chromosome, telomeric region,GO:0005578~proteinaceous extracellular matrix,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0071008~U2-type post-mRNA release spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR000467:G-patch domain,IPR022159:Tuftelin interacting protein N-terminal,IPR022783:GC-rich sequence DNA-binding factor domain,IPR024933:Septin and tuftelin interacting protein,			PIRSF017706:tuftelin-interacting protein 11,	SM00443:G_patch,	Alternative splicing,Biomineralization,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spliceosome,	chain:Tuftelin-interacting protein 11,compositionally biased region:Poly-Asp,domain:G-patch,modified residue,sequence variant,splice variant,
9736	ubiquitin specific peptidase 34(USP34)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016055~Wnt signaling pathway,GO:0016578~histone deubiquitination,GO:0016579~protein deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0000124~SAGA complex,GO:0005829~cytosol,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR016024:Armadillo-type fold,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,Wnt signaling pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 34,modified residue,sequence variant,splice variant,
64718	unkempt family like zinc finger(UNKL)	Homo sapiens				GO:0000209~protein polyubiquitination,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000571:Zinc finger, CCCH-type,IPR001841:Zinc finger, RING-type,				SM00356:ZnF_C3H1,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein unkempt-like,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type,
10090	uronyl 2-sulfotransferase(UST)	Homo sapiens				GO:0006477~protein sulfation,GO:0030010~establishment of cell polarity,GO:0030208~dermatan sulfate biosynthetic process,GO:0050770~regulation of axonogenesis,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,	IPR005331:Sulfotransferase,IPR007734:Heparan sulphate 2-O-sulfotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,				Complete proteome,Glycoprotein,Golgi apparatus,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Uronyl 2-sulfotransferase,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
7444	vaccinia related kinase 2(VRK2)	Homo sapiens			General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair,	GO:0006468~protein phosphorylation,GO:0008360~regulation of cell shape,GO:0016032~viral process,GO:0018105~peptidyl-serine phosphorylation,GO:0034599~cellular response to oxidative stress,GO:0043408~regulation of MAPK cascade,GO:0046777~protein autophosphorylation,GO:2000659~regulation of interleukin-1-mediated signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0043234~protein complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Endoplasmic reticulum,Host-virus interaction,Kinase,Membrane,Mitochondrion,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase VRK2,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,transmembrane region,turn,
29799	yippee like 1(YPEL1)	Homo sapiens					GO:0005634~nucleus,	GO:0046872~metal ion binding,	IPR004910:Yippee-like protein,					Complete proteome,Metal-binding,Nucleus,Reference proteome,Zinc,	chain:Protein yippee-like 1,sequence conflict,short sequence motif:Nuclear localization signal,
353174	zinc activated ion channel(ZACN)	Homo sapiens				GO:0007210~serotonin receptor signaling pathway,GO:0007271~synaptic transmission, cholinergic,GO:0010043~response to zinc ion,GO:0034220~ion transmembrane transport,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0016021~integral component of membrane,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0005232~serotonin-activated cation-selective channel activity,GO:0008270~zinc ion binding,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0042166~acetylcholine binding,	IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Zinc,	chain:Zinc-activated ligand-gated ion channel,compositionally biased region:Leu-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
140685	zinc finger and BTB domain containing 46(ZBTB46)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030853~negative regulation of granulocyte differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045656~negative regulation of monocyte differentiation,GO:2001199~negative regulation of dendritic cell differentiation,GO:2001200~positive regulation of dendritic cell differentiation,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Complete proteome,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 46,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:BTB,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,
92822	zinc finger protein 276(ZNF276)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR012934:Zinc finger, AD-type,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Centromere,Chromosome,Complete proteome,DNA-binding,Kinetochore,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 276,domain:ZAD,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
203523	zinc finger protein 449(ZNF449)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 449,domain:SCAN box,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
340385	zinc finger protein 517(ZNF517)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 517,domain:KRAB,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
51123	zinc finger protein 706(ZNF706)	Homo sapiens				GO:0006417~regulation of translation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1902455~negative regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0046872~metal ion binding,	IPR007513:Uncharacterised protein family SERF,IPR026939:Zinc finger protein 706,					Complete proteome,Cytoplasm,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Translation regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 706,zinc finger region:C2H2-type,
